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 Abstract 
         With the advent of chemoselective reactions and unnatural amino acids (UAAs), the 
fields of molecular biology and organic synthesis are merging. Researchers are developing 
synthetic tools and producing small molecules that are able to affect and investigate large 
biomolecules and complex living systems. This thesis undertakes a survey of synthetic 
techniques to develop novel tools that can be employed to address a variety of relevant 
biological questions. Specifically, we are investigating alternatives and improvements to 
caging groups, including photoreversible azobenzene UAAs and an UAA caging group 
possessing a bioorthogonal handle. Also, we are developing a novel system to undergo 
copper-free 1,3-dipolar cycloadditions, utilizing microwave irradiation. Adapting this 
methodology, we showcase the first transition and metal free bioconjugations utilizing 
microwave irradiation through CoolMate technology. Finally, we are examining a method 
to insert a highly reactive selenocysteine amino acid into proteins via the integration of a 
caging group and unnatural amino acid technologies.
1  
Chapter One: Introduction 
 
Within the realm of cellular biology and biochemistry, proteins are perhaps the 
most dynamic of the major macromolecules. Proteins act as the functional units of cells, 
performing the majority of the cellular chores. Proteins include enzymes which catalyze 
reactions, antibodies which protect the body from detrimental foreign particles, and 
transporters which allow certain substances in the cells. Each of the over 100,000 proteins 
are composed of twenty canonical amino acids in different 
numbers and combinations.1 Amino acids have a basic 
structure of an amino N-terminus and a carboxyl C-
terminus, connected by a singular carbon, which contains 
a functional R-group (Figure 1.1). The R-groups afford 
amino acid diversity, with the most simplistic being 
glycine, possessing a hydrogen atom as the R-group. Depending on the R-group, amino 
acids can have distinct chemical properties, such as polarity, hydrophobicity, and acidity.1,2 
Almost all naturally occuring amino acids are found in the L-configuration (which has the 
same nomenclature as the S configuration in stereochemistry).1 Amino acids are connected 
through a peptide bond, which is the result of a dehydration reaction between the N-
terminus of one amino acid with the C-terminus.1 Conversely, water is used to hydrolyze 
a peptide bond to form individual amino acids.1 
Figure 1.1: General structure of an amino acid. The N-terminus consists of an amino group, and the C-terminus consists of a carboxyl group. 
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 In cells, amino acids are polymerized 
into polypeptides during translation, where 
messenger RNA (mRNA) sequences are 
converted into amino acids via ribosomes 
and tRNAs. The original mRNA is 
fabricated using DNA as a template during 
transcription, where segments of DNA are 
copied into RNA, spliced into exons and 
introns, and then the exons combine to make messenger RNA.1 Nucleic acids differ in their 
nitrogenous base groups, where DNA has adenine, guanine, thymine and cytosine, and 
RNA has adenine, guanine, uracil, and cytosine.2 Triplet groups of nucleotides, known as 
codons, correspond to specific amino acids. Due to the number of possible nucleotide 
configurations and the relatively small number of amino acids, multiple nucleotide triplet 
combinations result in the same amino acid.2 This creates degeneracy in the genetic code, 
which is useful evolutionarily as it minimizes harmful mutations.2 Amino acids pair with 
codons through aminoacyl tRNA synthetases (aaRSs) and transfer RNA (tRNA).1,2 These 
aaRSs bind tRNAs, which contain an anticodon matching the codon of an mRNA. The 
specific amino acid also binds to the aminoacyl tRNA synthetase and is covalently linked 
to the tRNA molecule.1,2 Synthetases work in conjunction with ribosomes to couple amino 
acids together to form polypeptides and ultimately proteins (Figure 1.2).2,3 
 
 
 
Figure 1.2: Translation of amino acids from mRNA to form polypeptides. Amino acids are carried by tRNAs which have anticodons that bind to codons on the mRNA transcript. This process happens on ribosomes, which are a combination of protein and ribosomal RNA (rRNA).2,3 
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Unnatural Amino Acids 
Outside of the naturally occurring amino 
acids, researchers and genetic engineers have 
synthesized unnatural amino acids (Figure 1.3).4,5 
Unnatural amino acids (UAAs) allow for increased 
protein diversity by the addition of non-canonical 
moieties. For example, an amino acid can be 
constructed to undergo more complex organic 
reactions, such as Suzuki couplings and “click” 
reactions.6 To date, about one hundred amino acids 
have been synthesized and successfully integrated 
into proteins.7-8  
UAAs have been synthesized and incorporated into proteins for a variety of 
purposes. For example, a benzoyl phenylalanine derivative UAA has been incorporated 
into glutathione S-transferase.9 Upon irradiation, the benzophenone moiety is able to cross 
link protein subunits, acting as a photophysical probe.9 A boronate phenylalanine UAA 
was co-transformed into an antibody and was found to outcompete wildtype antibodies in 
binding to acylic glucamine resins.10 Unnatural fluorinated amino acids, such as m-fluoro-
phenylalanine, 4-fluoroproline, and trifluoroleucine, have been utilized to direct specific 
protein-protein interactions, especially with regards to protein folding.11 These fluorinated 
UAAs are also useful as probes, as they allow monitoring via 19F NMR, an analytical 
technique with high sensitivity relative to cellular environments.12 Moreover, they alter the 
Figure 1.3: A list of unnatural amino acids successfully synthesized. Each UAA has a unique R group, such as iron containing groups, polyaromatics, and terminal alkynes.5 
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chemical properties of the residue, providing new probes for electron transfer events, and 
residues with tunable pKa values.11 
Methods for Translation of Unnatural Amino Acids  
  The utility of UAAs, while immense, is also challenging. It is rather inefficient to 
chemically synthesize proteins with the desired amino acid or unnatural amino acid; 
therefore, the cell’s own machinery is often exploited. Bacteria are able to produce proteins 
in bulk if induced with specific small molecules.2 While the induction of protein synthesis 
is rather simple, the actual mechanism for inserting an unnatural amino acid into a protein 
is very complicated. This is because synthetase/tRNA pairs are generally coupled with a 
specific amino acid, and therefore will not accept a non-canonical amino acid.2 One 
solution to this involves introducing novel exogenous aaRSs that will carry out translation 
using only the UAA. This method requires that the tRNA and the tRNA synthetase be 
orthogonal to the endogenous translational machinery, so that no other synthetase will 
recognize the tRNA for the UAA.12 Since the genetic code is inherently degenerate, there 
are multiple sequences for stop codons (UAA, UGA, and UAG), which means that these 
codons can be exploited for the  incorporation of an unnatural amino acid.13 One advantage 
in using these stop codons is that they do not encode an amino acid, but rather they signal 
the termination of translation. Also, only one stop codon is necessary to terminate 
translation, and if the suppressor tRNA synthetase/tRNA pair is not present, translation 
simply halts.1,2  
One important methodology that involves tRNA synthetases is the engineering of 
optimized pEVOL plasmids to introduce the exogenous translational machinery (Figure 
1.4).14 Bacteria have circular double-stranded DNA sequences  called plasmids that are 
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separate from the bacterial chromosomal DNA.2 Plasmids usually contain some type of 
genetic advantage, such as antibiotic resistance, and these plasmids can be transferred 
amongst bacteria in several different fashions.2 Researchers have been able to manipulate 
these plasmids via molecular biology techniques 
to provide a platform for the expression of 
exogenous genes. In this method, unnatural amino 
acids are introduced into proteins in Escherichia 
coli using aaRSs and suppressor tRNA pairs 
evolved from Methanocaldoccus jannaschii.14 
Suppressor tRNA refers to utilizing the amber 
stop codon (UAG for RNA and TAG for DNA) as the unique codon that attaches to the 
anticodon (CUA) on the orthogonal tRNA. In this method, these plasmid vectors are linked 
to antibiotic resistance and protein synthesis induction.14  
Selection of aaRSs is accomplished via a series of positive and negative selections 
from a library (~108) of aaRS active site mutants (Figure 1.5).4 The positive selection is 
performed by transforming the cells 
with the library, as well as a mutated 
gene encoding chloramphenicol 
acetyl-transferase (CAT) with a 
TAG codon.4 CAT inactivates that 
antibiotic chloramphenicol, through 
a catalyzed acetylation. Therefore, 
when cells are grown in the 
pEVOL
6124 bp
aaRS
aaRS araC
CmR
araBAD
proK prom
glnS'
p15A
rrnB
proK termtRNA
pEV L 
Figure 1.4: A pEVOL plasmid that codes for the production of aaRSs that allow for the amino acid to be translated into a protein.14 There is also an araBAD that enhances protein expression.14 
Figure 1.5: Selection mechanism for aaRSs. Positive selection transforms plasmids that charge an UAA or a canonical amino acid onto a tRNA.4 Negative selection selects against aaRSs that encode canonical amino acids.4 
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presence of chloramphenicol, the cells that possess an aaRS that can bind to the tRNA will 
produce CAT and survive.4 This process occurs because the plasmid was mutated to 
introduce a codon that is complementary to the orthogonal UAA tRNA. Also, the aaRS has 
been mutated at the tRNA binding site to recognize the AUC anticodon, as well as at the 
amino acid binding side, to provide UAA recognition. Negative selection proceeds by 
transforming the same aaRS with a plasmid encoding a mutated barnase gene, a toxic 
ribonuclease.4 Cells are grown in the absence of UAAs to select against aaRSs that 
aminoacylate natural acids, by expressing barnase if the aaRS can read through the TAG 
codon.4 This prevents the selected aaRS from incorporating a canonical amino acid.4 
Positive and negative selections are repeated multiple times to ensure an aaRS is evolved 
to specifically incorporate the desired UAA. 
With the production of a variety of complex UAAs, creating and tuning individual 
novel aaRSs for individual unnatural amino acids can prove to be cumbersome. One 
alternative method is creating a synthetase that is able to encode a variety of amino acids.15 
These permissive synthetases allow for multiple UAAs to be integrated into proteins, rather 
than requiring a unique aaRS for each UAA.15 One example of this is the p-
cyanophenylalanine aminoacyl-tRNA synthetase (pCNF-RS), which is able to incorporate 
at least eighteen different UAAs in response to a TAG codon.15 These UAAs include 
trifluoroketone, alkynyl, and hydrazine UAAs.15 Another important facet for these 
unnatural aaRS’s is that the twenty canonical amino acids cannot be utilized by this 
synthetase, providing excellent bioorthogonality.15 
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Green Fluorescent Protein and Applications
 One model system for unnatural amino 
acids is Green Florescent Protein (GFP) 
expression, a fluorescent protein found in the 
jellyfish Aequoria victoria.  GFP is composed of a 
beta barrel with a tyrosine chromophore at residue 
66 (Figure 1.6).16 Residues 65-67 (Ser-Tyr-Gly) 
are theorized to undergo a condensation reaction resulting in a chromophore.16 An 
imidazolinone is formed by nucleophilic attack by the glycine amide on the carbonyl 
residue of serine, and this is followed by a dehydration reaction.16 It is then hypothesized 
that molecular oxygen dehydrogenates the α-β bond of tyrosine, allowing conjugation of 
the phenol ring to the imidazolinone.16 
GFP provides a powerful tool for analysis of UAAs, especially with regards to 
monitoring the ability of synthetases to incorporate unnatural amino acids.14 Competent 
bacteria are transformed with a pEVOL plasmid, with the respective aaRS/tRNA pair, as 
well as a plasmid with a GFP TAG mutation (Figure 
1.7).14 These mutations allow bacterial cells to 
transcribe and translate Green Fluorescent Protein. 
The TAG mutation is associated with a specific 
residue e.g. GFP 151 TAG and GFP 66 TAG, 
meaning that an unnatural amino acid can be placed 
specifically at that residue. With this procedure, 
bacterial cells are able to fluoresce only if the UAA is 
133 
151 3 
66 
Figure 1.6: Green Fluorescent Protein, with various residues shown within and around the beta barrel.16
pET101- GFPY151X 
Figure 1.7: A TAG plasmid that codes for production of GFP.14 Also, the plasmid incorporates a lac section that enhances protein expression, as well as ampicillin resistance.14 
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incorporated, which indicates the successful suppression of the stop codon with an UAA.14 
Moreover, a comparison can be made between wild type GFP and GFP with an unnatural 
amino acid to elucidate the effect of the UAA on the fluorescence and ultimately protein 
function.14 
Synthetic Plasmids 
As previously mentioned, certain segments of engineered plasmids are utilized for 
regulation of protein expression. In DNA, parts of the genetic material are devoted to 
modulating transcription.2 Portions such as promoters help initiate transcription of a gene, 
which is recognized by RNA polymerase, the protein that converts DNA to RNA.2 
Operators are segments of DNA where proteins can bind, and typically act as  repressors, 
which limits or stops expression.1,2 In the pET-GFP plasmid, there exists part of the lac 
operon, which normally regulates lactose metabolism, but here acts to control expression 
of GFP.13 One method of inducing GFP expression is with isopropyl β-D-1-
thiogalactopyranoside (IPTG), a reagent that binds to the lac repressor protein, resulting in 
its removal from the operator of the lac operon, allowing transcription to occur. RNA 
polymerase then can generate mRNA, which can be translated to afford GFP (Figure 
1.7).5,13,17 The pEVOL plasmid also contains an araBAD promotor that regulates 
production of the aminoacyl-tRNA synthetase.5,13,18, In E. coli, the araBAD operon is used 
to catabolize arabinose, which is a five carbon monosaccharide used in formation of 
pectin.18 PBAD is a promotor on the araBAD operon that is activated by arabinose itself, and 
therefore, when arabinose is introduced into a cellular culture, the PBAD promoter facilitates 
production of the aaRS in the pEVOL plasmid (Figure 1.4).5,13 
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One factor that must be addressed when discussing transformation of bacterial cells 
with aminoacyl-tRNA synthetases/tRNA pairs is ensuring that bacterial cultures have the 
specific synthetase/tRNA pair. One method to guarantee proper incorporation is 
associating the engineered plasmid with antibiotic resistance. Generally, the GFP-TAG 
plasmid contains an ampicillin resistance sequence (Figure 1.7).5,13,14,15 With this sequence, 
the bacteria are able to synthesize a β-lactamase enzyme that hydrolyzes β-lactam groups, 
which is the core structure of ampicillin, and thus deactivating the molecule.19 When the 
bacteria are transformed, they are grown on agar plates with ampicillin, and therefore, cells 
that do not retain the engineered plasmid do not inherit antibiotic resistance and will die. 
This same methodology can be applied with chloramphenicol resistance, to act as a 
secondary safeguard to ensure proper transformation.5,13,14,15 
Photochemistry and Caging Groups 
Manipulation of proteins provides a powerful tool as a therapeutic. Since amino 
acids are the molecules which determine shape and function of proteins, the editing of a 
single amino acid can have drastic effects on protein functionality. Unnatural amino acids 
have been incorporated into both prokaryotic and eukaryotic cells, which allows 
experimentation with bacteria, yeast, and even mammalian cells.10,13-15 Many diseases are 
caused by malfunctioning proteins, especially misfolded protein; therefore, options to 
internally correct these harmful proteins are necessary.9 
 One of the more interesting and important areas in biochemistry, especially with 
regards to amino acids, is the manipulation of proteins via photochemistry. Photochemistry 
provides great utility to controlling biological macromolecules, as light can be controlled 
with extreme precision, specifically with respect to location and time.20 Fluorescent and 
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UV/Vis equipment are also found ubiquitously in laboratories, making these technologies 
readily applicable. One advantage of using light is that certain reactions can be triggered 
using a specific wavelength light, without damaging the cell.20 Also, this non-phototoxic 
irradiation does not affect the cell normally; therefore, if certain photosensitive molecules 
are placed inside the cell, they can be safely reacted without fear of simultaneous reactions. 
 Recently, biochemists have taken interest in the utilization of caging groups. These 
caging groups are protecting groups that inactivate the molecule, but can easily be removed 
via irradiation of light.20 The most common caging groups are based on ortho-nitrobenzyl 
moieties; however, more advanced caging groups have been developed, such as a 
nitrodibenzofuran chromophore and 8-bromo-7-hydroxyquioline.20-22 One notable 
example of caging groups involves caged IPTG to control expression of genes under 
control of the lac operator.23 Caged IPTG was introduced into bacterial cells, and due to 
the caging group, IPTG was unable to bind to the lac repressor, but when irradiated, the 
caging group disassociated and IPTG removed the lac repressor allowing gene 
expression.23 This is significant, as IPTG decaging mimics the effect of adding decaged 
IPTG allowing gene expression to be turned on in a spatial and temporal fashion.23 
 While proteins can be affected by the caging of small effector molecules, they can 
also be regulated by caging of amino acids.20 This, however, is more difficult, as attempts 
to cage isolated amino acids on a protein 
surface are non-specific due to the fact that 
location of the caging group cannot always 
be ensured.20 Utilizing orthogonal 
synthetase/tRNA pairs has proved to be 
Scheme 1.1 
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useful in caging amino acids at specific residues.20  One example of this is light activated 
transcription via a photocaged tyrosine at residue 639 of a bacteriophage (Scheme 1.1).24 
The same methodology as described above was performed, where an amber stop codon 
was incorporated into a plasmid and transformed with the bacteriophage, such that a 
tyrosine with an ortho-nitrobenzyl caging group could be placed into an RNA polymerase 
enzyme.24 The caging group blocked the active site from the nucleotide, preventing 
transcription; however, after a brief radiation with non-cytotoxic UV light, the caging 
group was removed from the tyrosine residue and RNA polymerase functionality was 
restored.24 
 Caged amino acids have also found utility in mammalian cells. For example a caged 
lysine has been incorporated to control nuclear import of the tumor suppressor p53 (Figure 
1.8).25 An ortho-nitrobenzyl cage was synthesized and attached to lysine, such that an 
irradiation of light would decage the amino acid in a non- harmful manner.25 Researchers 
utilized an orthogonal MbPylRS/tRNA pair that is 
congruent with the amber stop codon, in order to 
facilitate protein synthesis with the caged lysine.285 
A single caged lysine was placed at position 305 of 
p53 utilizing the above method, and found that p53 
was largely unable to enter the nucleus of mammalian cells, due to the caging group 
disrupting the nuclear localization signal binding.25 Nuclear localization signals are used 
to import macromolecules into the nucleus, and without the tag, p53 was unable to enter. 
Subsequently, when the cell was photolysed with one second of 365 nm light, the lysine 
residue became decaged, and p53 was able to be imported from the cytosol to the nucleus.25 
Figure 1.8: (A) Photocaged serine. (B) Photocaged lysine. 
  
12  
In another experiment, a photocaged serine (4,5-dimethoxy-2-nitrobenzylserine) 
was inserted into Saccharomyces cerevisiae utilizing the previously described amber 
suppression (Figure 1.8).26 The caged serine unnatural amino acid was incorporated into 
the transcription factor Pho4 at serine residue 128.26 Pho4 is needed for the expression of 
a phosphate-repressible acid phosphatase, which acts to remove phosphate groups, and is 
especially involved in controlling the cellular response to inorganic phosphate.26,27 By 
caging the serine molecule, Pho4 was unable to be phosphorylated, which inhibited 
export.26 After irradiation, the free serine residue was able to be phosphorylated, and Pho4 
transport was restored.26 Experimentation was performed by fusing Pho4 with GFP, and 
tracking the movement of the transcription factor in real time.26 
Microwaves 
Within the field of synthetic chemistry, microwaves have gained prominence in the 
last thirty years due to the instrument’s reduced reaction time, high yields, and nuanced 
reaction effects.28 Microwaves function by exposing a substance to microwave radiation 
(wavelengths ranging from 1 m - 1 mm, and frequencies ranging from 300 MHz - 300 
GHz).28 When exposed to a microwave electromagnetic field, the dipoles of molecules will 
align with alternative motion of the electromagnetic waves. In a process known as 
dielectric heating, the alternating molecules collide and distribute energy with each other 
via their vibrating motions.28 The rise in average kinetic energy is proportional to a rise in 
temperature, which will uniformly heat the substance undergoing irradiation. Due to the 
necessity of a dipole, substances without a dipole moment typically do not generate heat 
under microwave conditions.  
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Since first used in the late 1970s in 
synthetic chemistry, microwave technology offers 
a powerful technique in the quick and efficient 
reaction of organic and inorganic compounds.29 
The main utility of microwaves is their ability to 
uniformly heat in a rapid fashion, compared to 
more standard methods of heating such as oil baths 
and heating jackets, which heat reaction vessels, 
but in a non-uniform fashion (Figure 1.9).30 Currently, microwave technology is used for 
a variety of synthetic reactions, such as Suzuki Coupling31, Krapcho decarboxylation32, 
and more broadly, in the synthesis of analgesic drugs33. One example of promising 
microwave technology is in 1,2,3 triazole cycloadditions (“click” chemistry).34  
  
 
Figure 1.9: Temperature readings of two heating methods. Microwaves uniformally heat the reaction mixture, compared to an oil bath, which  heats the reaction mixture non-uniformally.30 
  
14  
Chapter 2: Photoisomerable Azobenzene UAAs 
The discovery of GFP prompted a surge in the engineering of switchable GFP 
hybrids. While GFP is able to fluoresce, a useful feature, the ability for a fluorescent protein 
to switch its state of fluorescence provides a superior resource for researchers. For example, 
photoswitching proteins can assist in live-cell imaging, information storage, protein 
control, and protein tracking.35 The first few 
switchable fluorescent proteins that were 
generated were unable to provide a high contrast 
in their switching ability, limiting their utility.35 
These proteins included Yellow Fluorescent 
Protein (YFP), Cyan Fluorescent Protein (CFP), 
and Citrine.35 The first widely used switchable 
protein was Kindling Fluorescent Protein (KFP), which was able to track protein 
movements in vivo.35 Shortly following the development of KFP, Dronpa, a 
photoswitchable fluorescent protein derived from stony coral, was engineered.36 Dronpa 
has the ability for its baseline “on” stage to be turned “off” via irradiation with light (Figure 
2.1) .35,36 Several mutants of the protein were created that alter Dronpa’s photoswitching 
kinetics, such as Dronpa-2 and Dronpa-3.36 Another Dronpa mutant, Padron, has a reverse 
characteristic from Dronpa, where its baseline state is “off”, and irradiation of light 
switches the photoswitchable fluorescent protein “on”.36  
 Green Fluorescent Protein has a particular excitation spectrum, where there are 
normally two excitation peaks at 395 nm and 475 nm. When UV light is irradiated, or the 
pH is changed, the large peak at 395 nm diminishes while the smaller peak at 475 nm 
Figure 2.1: (a) Photoswitching involves cis–trans isomerization in Dronpa (b) trans–cis isomerization in Padron.35 
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rises.16 This change has to do with altering protonation states of the tyrosine amino acid at 
residue 66.16,36 GFP has been coupled with UAA research, for example, using orthogonal 
aminoacyl-tRNA synthetases, unnatural amino acids were able to replace the fluorophore 
tyrosine.16 Unnatural tyrosines with the phenol replaced with boronate, azido, nitro, and 
keto groups were put into residue 66 and analyzed for alterations in fluorescent 
properties.16 The scans showed reduced or no fluorescence intensities, while also showing 
shifted emission maxima, for the UAA-protein complexes with reduced intensities.16,36 
Photo-Reversible Amino Acids and Domains 
 One major problem with 
caging groups is that they are not 
reversible, meaning after irradiation 
and decaging, the effector molecule or 
amino acid cannot be recaged. Therefore, when researchers need photoreversibility, one 
method they employ is photoisomerable molecules, such as molecules with azobenzene 
moieties.37 Azobenzene naturally exists in the more stable trans formation; however, when 
irradiated with light, azobenzene molecules shift to a cis formation (Scheme 2.1).37 This 
has been utilized in controlling ion channels, where an azobenzene molecule can become 
attached to the protein via reacting 
with a nucleophile via ligand binding, 
or subsequently become incorporated 
into the protein’s primary structure.37 
In one experiment, the azobenzene 
molecule was reacted with a charged Figure 2.2: Examples of azobenzene derivatives, and their utility as ion channel regulators.37 
Scheme 2.1 
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ammonium substrate on the terminal benzene group, such that when the molecule was 
irradiated, it would shift to the cis position, blocking ions from entering the ion channel 
(Figure 2.2).37 Gratifyingly, the azobenzene molecule can shift back either thermally or 
with irradiation at a separate wavelength, reverting the ion channel to normal 
functionality.37 
 One other reversible system employed is the fusing of Light-Oxygen-sensing 
domains (LOVs) to proteins.38 LOV domains are bound to a flavin mononucleotide (FMN) 
cofactor, which undergoes a  conformational change when 
irradiated with light at 450-470 nm.38 The change in protein 
structure is a result of the unwinding of a helical domain 
near the LOV domain, which acts as a signaling message to 
attached effector protein (Figure 2.3).38 In one experiment, 
a LOV domain replaced the chemosensor domain of a 
histidine kinase.39 The kinase is traditionally light inert; 
however, after replacement with the LOV domain, kinase 
activity was repressed when illuminated with light.39 Kinase activity was restored after 
thermal recovery, but only recovered after an intermediary lag phase.39 With the 
importance of reversible moieties apparent, we propose an 
azobenzene unnatural amino acid to be synthesized and inserted 
into GFP (Figure 2.4). The fluorescence of GFP will be 
measured while the azobenzene UAA is in the trans and cis 
positions.  
 
Figure 2.3: An example of a conformational change of a flavin mononucleotide, unwinding the LOV domain, and signaling an effector protein.38 
Figure 2.4: A proposed azobenzene unnatural amino acid. 
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Scheme 2.2 
Results and Discussion  Azobenzene UAA:   The synthesis of 1 was performed under relatively mild conditions, utilizing a Mills 
reaction.40,41 The Mills reactions proceeds via attack of the nitroso by the aniline, followed 
by removal of water (Scheme 2.2). Hydrochloric acid was then used to remove the Boc 
group. Due to the native charged state of amino acids, normal purifications methods were 
not possible. Therefore, the reaction was simply concentrated with a rotary evaporator, for 
a modest 61% yield. When making a stock solution for protein expression, 1 was not able 
to be dissolved in water. However, the insolubility was addressed via sonication and 
addition of NaOH, which was needed to neutralize 1 from the deprotection step. To enable 
incorporation of 1 into GFP, competent cells were co-transformed with an Azobenzene 
pEVOL-tRNA synthetase plasmid and four separate pET-GFP-TAG plasmids containing 
TAG mutations at residues 3, 66, 133, and 151. Mutant GFPs were obtained utilizing the 
general GFP expression as will be described. Cell cultures were induced with 1, to afford 
GFP with an incorporated azobenzene unnatural amino acid.   
 
 
Various buffers were analyzed for the fluorescence measurements, including 5X 
Tris Buffer, 1X Tris Buffer, and PBS. It was originally assumed that due to the low salt 
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concentrations, 1X buffer and PBS would be the most consistent, but it was demonstrated 
empirically that 5X Tris buffer yielded the most consistent spectra. Each of the four GFP 
mutants with 1 were examined before, immediately after, and at several hours after 
irradiation at 365 nm. Different irradiation time lengths were employed, and 10 minutes of 
irradiation was found to be optimal for full photoisomerization of the azobenzene UAA. 
Full thermal photoisomerization to the trans position was observed after approximately 16 
hrs. From the fluorescence experiments, addition of 1 to each of the GFP four residues was 
demonstrated to shift the emission spectrum of the protein (Figure 2.5). Irradiation resulted 
in drastic emission shifts to higher wavelengths, while thermal recovery restored emission 
to pre-irradiation levels (Figure 2.6). This demonstrates the photoisomerability of the 
azobenzene UAA, as it is able to alter protein function when irradiated, and also restore 
native function.  
 
 
Figure 2.5: Emission scans for GFP mutants containing 1 at various residues, compared to GFP wt (orange).42 Interestingly, for each GFP mutant, the emission peak rose significantly for the 475 nm peak, while falling greatly at the 510 nm peak. 
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Figure 2.6: Emission scans for GFP mutants containing 1 at residue 66. UV irradiation prompted great shifts to lower wavelengths of light, compared to GFP wt.42 Also, recovery of the GFP mutant is shown via the green line, demonstrating the photoisomerability of the UAA. 
 
Given the photoswitching observed by fluorescence spectroscopy, spatial control 
over GFP fluorescence was attempted. LB Agar plates containing the inductants and the 
unnatural amino acid 1 were prepared and E. coli harbouring the pET-GFP-Y66TAG 
plasmid and the pEVOL-Azobenzene plasmid were plated and allowed to grow overnight 
at 37° C. After a bacterial lawn was 
formed, an aluminum foil mask was 
placed over half of the plate to block 
UV irradiation. When irradiated for 15 
minutes or longer, photobleaching 
occurred, preventing the detection of 
photoisomerization. The optimal 
irradiation conditions were ultimately found to be 10 min at 365 nm. Excitingly, a 
differential fluorescence was observed only on cells that were exposed to UV irradiation 
(Figure 2.7). After a 4 h recovery in the dark at room temperature the plate was imaged 
Figure 2.7: A spatial control experiment demonstrating both the ability of 1 to change the fluorescence of GFP after UV irradiation, and reversibly photoisomerize, restoring pre-irradiation fluorescence.42 
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again, and the differential fluorescence was absent, signifying a reversion to the trans form 
of the fluorophore. The result demonstrates the ability to ‘switch’ the GFP fluorescence in 
a spatial and temporal fashion. Moreover, only slight photobleaching was observed when 
the wild type GFP was expressed and irradiated on the plates, and no recovery was 
observed 
Azobenzene Alkyne UAA:  The ability to control the wavelength of light needed to photoisomerize an 
azobenzene unnatural amino would be useful if applied to living systems. Azobenzene 
isomerizes at 365 nm, a cytotoxic wavelength, which would not be applicable in vivo. 
Derivatizing the para position of the terminal benzene is 
hypothesized to shift the isomerization wavelengths, such 
that photoisomerization of an azobenzene UAA would be 
accomplished at non-toxic wavelengths.43 Adding an 
alkyne derivative would enhance the conjugation of the 
azobenzene moiety, which could shift the isomerization wavelengths, but also act as a 
biorthogonal handle (Figure 2.8). Terminal alkyne groups can undergo bioconjugation via 
click and Glaser-Hay reactions, as will be described in the following sections. This allows 
for dyes, proteins, and other macromolecules to be attached to a protein with 5. 
Synthesis of 5 was first attempted via a standard azo coupling, in which a para-
amino group is converted into a diazonium group via sodium nitrite and a strong acid 
(Scheme 2.3).43 The diazonium group acts as an electrophile and will couple to the para 
position of activated aromatics at a neutral pH, hence the addition of sodium hydroxide. 
Hydrochloric acid was first investigated as the acid source; however, it appeared that the 
Figure 2.8: An azobenzene alkyne UAA 
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Scheme 2.3 
tert-butyloxycarbonyl (Boc) group of the 4-Amino-N-(tert-butoxycarbonyl)-L-
phenylalanine was also being deprotected. This resulted in diazonium formation of the N-
terminus and the para-amino group of the 4-Amino-N-(tert-butoxycarbonyl)-L-
phenylalanine molecule. Glacial acetic acid was then tested as the acid source, but it was 
not strong enough to generate the diazonium group. NMR of the reaction indicated that 
there was only starting material.  
  
 
Consequently, an alternative synthetic method was then employed, utilizing a 
similar mechanism as employed for the azobenzene UAA 1 (Scheme 2.4). This involved 
oxidizing the amino group of TMS ethynyl aniline molecule into a nitroso group. The 
nitroso group was then reacted with the 4-Amino-N-(tert-butoxycarbonyl)-L-
phenylalanine in a condensation reaction to form the azo group. The product was difficult 
to separate via flash chromatography, due to the similarities of the reactants and products. 
Despite a high 30:1 DCM:MeOH eluent system, poor separation still occurred, which 
would inflate the yields because of the remaining starting material. Based off NMR data, 
the yield was determined to be a poor 20 %.  
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It was then attempted to simultaneously cleave both the TMS and Boc protecting, 
utilizing HCl (2 mL, 4 N), but the reaction failed to remove the TMS group. Due to the 
polar N-terminus being exposed, most purification and separation methods could not be 
utilized. To cleave the TMS group, the product was reacted with potassium carbonate (5 
mg) in methanol (3 mL). This, however, also failed to cleave the TMS protecting group. In 
a separate synthesis, two individual deprotection steps were then employed to cleave the 
two protecting groups. The first step removed the TMS group with TBAF in DCM. Based 
on NMR analysis, the TMS deprotection was successful. Interestingly, after extraction and 
flash chromatography, the 1H NMR indicated three alkyne peaks. We hypothesize this 
could be a result of isomerization of the azo moiety. The second step then successfully 
cleaved the Boc group with HCl. 
Incorporation of 5 into GFP proceeded with significant difficulties. It was first 
attempted to utilize the Azobenene pEVOL synthetase that incorporated 1, as 5 possesses 
a similar structure to the previously incorporated 1. pET-plasmids for GFP 3, 66, 133, and 
151 were examined to incorporate 5, in a similar method as described above. Protein 
Scheme 2.4 
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Scheme 2.5 
expression and purification isolated GFP, but in order to test if 5 had been properly inserted, 
two experiments were performed. The first was a similar fluorescence test for the 
azobenzene UAA, via excitation at 300 nm, 320 nm, and 395 nm. Emission spectra both 
before and after fluorescence indicated novel fluorescence, which could confirm the 
presence of 5. A second test was devised that took advantage of the alkyne functional group 
of 5. A Glaser-Hay bioconjugation was performed on the proteins with a fluorescent dye 
(Scheme 2.5).44 A control reaction was performed with both protein and fluorophore, but 
without the copper iodide and TMEDA. The bioconjugated protein was then analyzed via 
SDS-PAGE, in which the protein should fluoresce on the gel. Unfortunately, no 
fluorescence was observed. This could be due to dilute protein indicating poor 
incorporation, or that the synthesized UAA is not actually 5, but rather an impurity 
(potentially of 1).  
  
The synthesis was repeated and 5 was attempted to be incorporated into GFP 
utilizing the Azobenzene pEVOL synthetase plasmid. However, this expression yielded no 
GFP after expression and purification. Thus it was hypothesized that this aaRS may not be 
able to effectively incorporate 5, requiring either an alternative aaRS or an aaRS evolution 
using 5. For simplicity an assay was performed to identify a potential aaRS that would 
recognize and incorporate 5. The pEVOL synthetases Nap, CouA, pCNF, pAzF, and pPrF 
plasmids were each transformed with a pET-GFP-TAG 151 plasmid. Cultures were grown, 
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and GFP was induced in a 96-well plate with appropriate expression controls, as described 
in the general aaRS assessment protocol. Fluorescence of the cell cultures were measured 
on a microplate reader after 16 hours of expression. The pAzF synthetase appeared to 
incorporate 5 at a relatively higher rate than the control (Figure 2.9). GFP containing 5 was 
then expressed and purified utilizing the pAzF pEVOL plasmid; however, no GFP was 
produced on this large scale. This could be due to the pAzF plasmid incorporating 5 poorly, 
but enough to indicate a higher result than the control.  
 
Figure 2.9: Synthetase assay for 5. Five synthetases were tested for their ability to incorporate 5 into GFP at residue 151. The synthetase pAzf showed the most promise, as fluorescence measurements deviated the most from the control. 
 
 Despite current efforts, it appears that 5 has not been incorporated into GFP with 
high yields. One possibility is that the most recent synthesis is not 5; however, an LCMS 
was run confirming that 5 has been properly synthesized. Another synthetase assay could 
be run, testing a variety of synthetases with large binding pockets. Alternatively, a selection 
could be performed that would evolve a synthetase to incorporate 5.  
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Experimental 
General: Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Reactions were conducted 
under ambient atmosphere with non-distilled solvents. NMR data was acquired on a Varian 
Gemini 400 MHz. Fluorescence data were measured using a PerkinElmer LS 55 
Luminescence Spectrometer and a Synergy Microplate reader. All GFP proteins were 
purified according to manufacturer’s protocols using a Qiagen Ni-NTA Quik Spin Kit. 
General GFP Expression: A pET-GFP-TAG plasmid (0.5 μL) was co-transformed with 
a pEVOL-tRNA synthetase plasmid (0.5 μL) into Escherichia coli BL21(DE3) cells using 
an Eppendorf eporator electorporator. The cells were then plated (100 μL) on LB agar in 
the presence of chloramphenicol (34 mg/mL) and ampicillin (50 mg/mL) at 37° C 
overnight. One colony was then used to inoculate LB media (4 mL) containing both 
ampicillin and chloramphenicol. The culture was incubated at 37° C overnight and used to 
inoculate an expression culture (10 mL LB media, 50 mg/mL Amp, 34 mg/mL Chlr) at an 
OD600 0.1. The cultures were incubated at 37° C to an OD600 between 0.6 and 0.8, and 
protein expression was induced by addition of the respective unnatural amino acid (100 
μL, 100 mM) and 20 % arabinose (10 μL) and 0.8 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG; 10 μL). The cultures were incubated at 30° C for 16-20 h 
then pelleted at 5,000 rpm for 10 minutes and stored at -80° C for 3 hours. The cell pellet 
was re-suspended using 500 µL of Bugbuster (Novagen) containing lysozyme, and 
incubated at 37° C for 20 minutes. The solution was transferred to an Eppendorf tube and 
centrifuged at 15,000 rpm for 10 minutes, then the supernatant was added to an equilibrated 
column of Ni-NTA resin (200 µL) and the GFP was purified according to manufacturer’s 
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protocol. Purified GFP was analyzed by SDS-PAGE (BioRad 10 % precast gels, 150 V, 
1.5 h), and employed without further purification. Gels were imaged on a BioRad 
Molecular Imager (Gel Doc XR+) after being stained with Coomasie Brilliant Blue for an 
hour. The gel was then destained utilizing destain solution (60 % deionized water, 30 % 
methanol, 10 % acetic acid) until the gel was clear, after which the gel was analyzed via 
the Coomasie protocol on the BioRad Molecular Imager. 
General aaRS Assessment: The aaRSs were assessed for unnatural amino acid 
incorporation by first co-transforming a pET-GFP-TAG variant plasmid (0.5 μL) with a 
pEVOL-tRNA synthetase plasmid (0.5 μL), in a similar method as described previously. 
For each pEVOL plasmid, one colony was used to inoculate LB media (4 mL) in separate 
containers that contained ampicillin (4 μL, 50 mg/mL) and chloramphenicol (4 μL, 34 
mg/mL). The cultures were incubated at 37° C overnight. Expression cultures were created 
containing LB media (4 mL), ampicillin (4 μL, 50 mg/mL), and chloramphenicol (4 μL, 
34 mg/mL), and then were inoculated with the previous culture (250 μL). The expression 
cultures were incubated at 37° C to an OD600 between 0.6 and 0.8. Protein expression was 
induced by addition of 20 % arabinose (4 μL), and 0.8 mM IPTG (4 μL). The cultures were 
then plated on a 96-well plate (200 μL), with six wells for each plasmid. Three wells were 
designated as controls, and the other three were designated for the experiment. The 
designated UAA (100 μL, 100 mM) was added to the experimental wells only. The plate 
was allowed to shake at 30° C for 16 h, after which it was measured for fluorescence (528 
nm and 485 nm) utilizing a Synergy HT microplate reader.  
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Azobenzene UAA 
(E)-2-ammonio-3-(4-(phenyldiazenyl)phenyl)propanoate, 1: The unnatural amino acid 
was prepared according to literature conditions.40 To flame dried round bottom was added 
4-Amino-N-(tert-butoxycarbonyl)-L-phenylalanine (1.007 g, 3.59 mmol, 1 equiv.) and 
glacial acetic acid (200 mL). Nitrosobenzene (579 mg, 540 mmol, 1.5 equiv.) was then 
added and stirred for 16 hours. The reaction was then quenched with dI water (100 mL). 
The product was extracted with ethyl acetate (3 x 20 mL), and the organic layer was then 
back-extracted with brine (2x30 mL). The organic layer was isolated, dried with MgSO4, 
filtered, and solvent was removed by rotatory evaporation.  The orange solid was purified 
via flash chromatography with a 9:1 DCM/Methanol eluent. The product was concentrated 
and dissolved in Dioxane (4 mL), and cooled in an ice bath. To the solution, 6N HCl (2 
mL) was added and stirred for 3 hours. The solvent was then removed in vacuo to afford 
the deprotected azobenzene amino acid as an orange solid in a 61% yield (590 mg, 2.19 
mmol). 
Fluorescence Measurements: Each fluorescence spectrum was obtained in a glass cuvette 
with Tris Buffer (3 mL). To the cuvette, the desired GFP mutant protein was added (10 μL; 
0.3 mg/mL). Irradiation results were achieved via irradiating the cuvette with the protein 
at 365nm for 10 minutes, followed by immediate spectral measurements. The sample was 
excited at 300 nm and the emission spectral was recorded from 320 nm to 500 nm, 320 nm 
and the emission spectral was recorded from 350 nm to 550 nm, and 395 nm and the 
emission spectral was recorded from 415 nm to 600 nm. The excitation slit width was set 
to 10 nm, and emission slit width was set to 10 nm. Scan speed was set to 400 nm/min. 
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Spatial Control of Azobenzene GFP Fluorescence:  Agar plates (10 mL LB agar/plate; 
60 mm X 15 mm) containing Ampicillin (10 μl), Chloramphenicol (10 μl), 10% Arabinose 
(10 μl), and 1 M Isopropyl β-D-1-thiogalactopyranoside (10 μl) were prepared. Some plates 
were supplemented with a 100 mM L-phenylalanine-4’-azobenzene mixture to a final 
concentration of 1 mM, and other plates were prepared in the absence of the unnatural 
amino acid. E.coli BL21(DE3) cells (50 μL) containing the pEVOL-Azobenene plasmid 
and pET-GFP-Y66TAG were added to each plate and incubated overnight at 37 oC to 
afford a bacterial lawn. A plate containing the UAA and all inductants was half-covered 
with aluminum foil and irradiated at 365 nm for 10 minutes following imaging on a BioRad 
gel imaging system with the appropriate UV filters. The plate was then allowed to recover 
for 4 hours at 37 oC followed by re-imaging.  
 
Azobenzene Alkyne UAA 
First Method 
(E)-2-((tert-butoxycarbonyl)amino)-3-(4-((4-ethynylphenyl)diazenyl)phenyl)-
propanoic acid, 2: 4-Amino-N-(tert-butoxycarbonyl)-L-phenylalanine (100 mg, 0.357 
mmol, 1 equiv.) was added to a flame dried round bottom, and dissolved with glacial acetic 
acid (1 ml). The solution was warmed until it dissolved, and then cooled to 0° C. In an 
Eppendorf tube, sodium nitrite (44 mg, 0.64 mol, 2 equiv.) was dissolved in deionized 
water (330 μl). The contents of the Eppendorf were added to round bottom and allowed to 
stir for 45 mins at 0° C. To the solution was added ethynylbenzene (50 μl, 0.455 mmol, 1.5 
equiv.) and sodium hydroxide (3400 μl, 1 M) to neutralize the solution. The solution was 
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allowed to stir for 2 hrs at 0° C. The reaction was quenched with sodium bicarbonate (100 
μl). The product was extracted with ethyl acetate (3 x 20 mL), and the organic layer was 
then back-extracted with brine (3 x 30 mL). The organic layer was isolated, dried with 
MgSO4, filtered, and solvent was removed by rotatory evaporation.  The subsequent 
solution was purified via flash chromatography with a 10:1 DCM/Methanol eluent. 
Second Method 
Trimethyl((4-nitrosophenyl)ethynyl)silane, 3: To a flame dried vial was added Oxone 
(320 mg, 1.04 mmol, 2 equivalents) with deionized water (3 ml), and stirred for 10 mins. 
The contents of the vial were then added to a flame dried round bottom with 4-
[(Trimethylsilyl)ethynyl]aniline (100 mg, 0.53 mmol, 1 equivalent) and dichloromethane 
(3 mL). The reaction was stirred overnight at room temperature. The product was then 
extracted with dichloromethane (3x20 mL), and the organic layer was then back-extracted 
with brine (3 x 30 mL). The organic layer was isolated, dried with MgSO4, filtered, and the 
solvent was removed by rotatory evaporation. The product was advanced to the next step 
without further purification.  
(E)-2-((tert-butoxycarbonyl)amino)-3-(4-((4-((trimethylsilyl)ethynyl)phenyl)-
diazenyl)phenyl)propanoic acid, 4: In a flame dried vial, 4-Amino-N-(tert-
butoxycarbonyl)-L-phenylalanine (150 mg, 0.54 mmol, 2 eq) was dissolved in glacial 
acetic acid (3 ml). The contents of the vial were transferred to a round bottom containing 
3 (50 mg, 0.22 mmol, 1 eq) dissolved in acetic acid (3 ml), and left to stir overnight. The 
product was extracted with dichloromethane (3 x 20 mL), and the organic layer was then 
back-extracted with brine (3 x 30 mL). The organic layer was isolated, dried with MgSO4, 
filtered, and solvent was removed by rotatory evaporation.  The subsequent solution was 
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purified via flash chromatography with a 20:1 DCM/Methanol eluent, resulting in a brown 
solid (50 mg, 0.11 mmol, 20 % yield). 1H NMR (400 MHz; CDCl3): ∂ 8.258 (d, J=1.2 Hz, 
2H), 8.151 (d, J=8.6 Hz, 2H), 7.859 (d, J=7.4 Hz, 2H), 7.630-7.552 (m, 2H), 4.609-4.607 
(m, 1H), 3.268-3.208 (m, 2H), 1.255 (s, 6H), 0.007 (s, 6H). 
(E)-2-((tert-butoxycarbonyl)amino)-3-(4-((4-ethynylphenyl)diazenyl)phenyl)-
propanoic acid, 2: In a flamed dried round bottom, 4 (50 mg, 0.11 mmol, 1 eq) was 
dissolved in dichloromethane (3 ml), and tetra-n-butylammonium fluoride (68 mg, 0.22 
mmol, 2 eq). The reaction was stirred for 4 hrs at room temperature. The product was 
extracted with dichloromethane (3 x 20 mL), and the organic layer was then back-extracted 
with brine (3 x 30 mL). The organic layer was isolated, dried with MgSO4, filtered, and 
solvent was removed by rotatory evaporation.  The subsequent solution was purified via 
flash chromatography with a 30:1 DCM/Methanol eluent, resulting in a brown solid (30 
mg, 0.08 mmol, 70 % yield). 1H NMR (400 MHz; CDCl3): ∂ 8.289 (d, J=9 Hz, 2H), 8.166 
(d, J=8.6 Hz, 2H), 7.909 (m, 2H), 7.658-7.560 (m, 2H), 4.321 (t, 1H), 3.615-3.610 (m, 2H), 
3.251 (t, 1H), 1.262 (s, 6H).   
(E)-1-carboxy-2-(4-((4-ethynylphenyl)diazenyl)phenyl)ethan-1-aminium, 5: In a 
flamed dried round bottom, 2 (30 mg, 0.08 mmol, 1 eq) was dissolved in 1,4-Dioxane (4 
mL), and cooled in an ice bath. To the solution, 6N HCl (2 mL) was added and stirred for 
3 hours. The solvent was removed in vacuo to afford the deprotected azobenzene alkyne 
amino acid as a brown solid (23 mg, 0.08 mmol, 99% yield). 
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Chapter 3: A Photosensitive Propargyl Tyrosine UAA 
 Proteins are diverse and complex macromolecules, and are often difficult to tag or 
modify, especially under physiological conditions. With the discovery of chemoselective 
reactions, macromolecules can be covalently linked, even in complex cellular 
environments.45 This process is often referred to as a bioconjugation reaction, and provides 
a powerful tool to modify proteins through coupling with biophysical probes46,47, 
therapeutic agents48, or surfaces49. For example, the bioconjugation of naturally occurring 
thiol groups on cysteine residues with iodoacetamides has been utilized to determine the 
number of free cysteine residues in a protein.50 Unnatural alkyne handles enable 
bioconjugation techniques such as click and Glaser-Hay reactions.44,51 These reactions 
represent highly chemoselective covalent modifications that will be discussed in greater 
detail in the following sections. 
As previously mentioned, caging groups offer the ability to exogenously control 
protein function in a spatial and temporal fashion. The caging groups inactivate the protein, 
and when cleaved with light, protein functionality is 
restored.23-25 While the caging group can act as protein 
modifier, functional groups can be added to enhance its utility. 
A proposed unnatural amino acid containing an ortho-
nitrobenzene backbone with an alkyne handle would allow 
bioconjugation and photocleaving of the caging group (Figure 
3.1).  This UAA, once incorporated into a protein, could be conjugated to a drug, introduced 
into a cell, and then release the drug via photocleavage of the caging group (Scheme 3.1).52 
Figure 3.1: Proposed nitro-propargyl tyrosine unnatural amino acid. The UAA possesses both a caging group and an alkyne handle. 
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Scheme 3.152 
This would allow both spatio-temporal control of drug release, and the removal of the drug 
from the sterics of the protein. 
 
 
Results and Discussion: 
Synthesis of 11 proceeded via the proposed route (Scheme 3.2), with minor alterations. 
The propargylation of vanillin (6) was performed from a literature precedent and was 
achieved via nucleophilic attack of the phenoxide to the electrophilic propargyl bromide 
(Scheme 3.3).53 It was found that using anhydrous DMF and increasing the equivalents of 
propargyl bromide from 3 equivalents to 5 equivalents, increased the yield from 70 % to 
81 %. 
  
33  
Scheme 3.3 
Scheme 3.2  
 
 
 
 
 
Installation of a nitro group was accomplished by reacting 6 with nitric acid, via an 
electrophilic aromatic substitution (Scheme 3.4). The product was collected via Büchner 
filtration, with the solid being 7. The NO2 cation is generated by loss of water, followed by 
attack by the nucleophilic aromatic group. Proton abstraction by water restores aromaticity. 
A decreased yield was observed on a large scale, but when the flow through from the 
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Scheme 3.4 
Scheme 3.5 
Büchner filtration was resubmitted to reaction conditions after cooling, the resulting yield 
increased to 81 %.  
 
   
The reduction of 7 to 8 proceeded via attack of a hydride ion from sodium 
borohydride at the electrophilic aldehyde, generating a tetrahedral alkoxide intermediate 
(Scheme 3.5). In previous attempts, it was realized that the hydride ions were quenched by 
reaction with ethanolic protons, resulting in low yields. This was remedied by conducting 
the reaction in 1 M NaOH. The reaction was extracted and concentrated with a rotary 
evaporator, requiring no flash chromatography, resulting in a modest 76 % yield. 
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Scheme 3.6 
Bromination of 8 to 9 was then attempted using activated nucleophilic substitution. 
The nucleophilic alcohol of 8 reacts with PBr3, displacing a bromine ion (Scheme 3.6). The 
resulting phosphorous ester is a good leaving group, and is displaced after nucleophilic 
attack by the bromine ion, forming the C-Br bond. The phosphonic dibromide is a better 
leaving group than bromine, thus equilibrium favors the brominated product. A 50 % yield 
was obtained after extraction and flash chromatography. 
 
 
 The formation of the amino acid precursor 10 was found to be optimal under 
microwave conditions. Previous attempts reacted NaH and diethyl acetamidomalonate in 
DMF; however, no product was observed. It was found that the reaction could proceed to 
completion under microwave irradiation, based off literature precedence (Scheme 3.7).54 
The microwave irradiation resulted in several changes to previously described procedures. 
Due to the high reactivity, Cs2CO3 was employed in place of NaH. Moreover, the inability 
of DMF to tolerate large amounts of microwave energy prompted the use of acetonitrile. 
Due to the nature of the microwave vials, only 100 mg of 9 could be reacted at a time. After 
10 minutes of irradiation at this temperature, a 79 % yield was achieved after extraction 
and flash chromatography.  
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Scheme 3.7 
Scheme 3.8 
  
 
The conversion of 10 to 11 also proceeded via microwave irradiation using 6 N HCl 
(Scheme 3.8).54 Poor solubility of compound 10 was observed; however, as the reaction 
proceeded, the more water soluble 11 was generated. This resulted in aggregation of 10, 
and therefore the reaction had to be performed multiple times to achieve high yields. Due 
to the charged amino acid backbone, the reaction could not be extracted, nor purified by 
traditional silica gel column chromatography. Additionally, the deprotection step is not 
stereoselective, resulting in a racemic mixture of (D) and (L) diastereomers. Since only (L) 
amino acids can be translated by ribosomes, only half of 11 can be incorporated into 
proteins. However, based on NMR and LC/MS analysis, 11 was found to be present in 
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relatively high purity and a yield of 95 %. With the UAA in hand, we were next ready to 
attempt incorporation into a protein. 
 Since no aaRS has previously been evolved to specifically incorporate 11, an assay 
was performed to identify if any already existing aaRS was promiscuous for 11. The 
pEVOL synthetases Nap, BipY, pCNF, and ONBY plasmids were chosen due to their large 
binding pockets, or similarities to their corresponding UAA, and were each transformed 
with a pET-GFP-TAG 151 plasmid. Cultures were grown, and GFP was induced in a 96-
well plate with appropriate expression controls, as described in the general aaRS 
assessment protocol. Fluorescence of the cell cultures was measured on a microplate reader 
after 16 hours of expression (Figure 3.2). While most aaRSs were not able to accommodate 
the UAA, the results indicate that the pCNF-aaRS was able to incorporate 11 when 
compared to a negative control in the absence of the UAA. 
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Figure 3.3: SDS-PAGE analysis of GFP expression in the presence and absence of 11. Some protein is seen in the –UAA lane due to the promiscuity of the pCNF synthetase, as it is able to take in tyrosine. 
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Figure 3.2: Synthetase assay for 11. Four synthetases were tested for their ability to incorporate 11 into GFP at residue 151. The synthetase pCNF showed the most promise, as fluorescence (and therefore UAA incorporation) was highest relative to the control. 
  
38  
Incorporation of 11 into GFP at 
residue 151 via pCNF-aaRS was attempted on 
a 10 mL scale, and gratifyingly, protein 
expression was observed via SDS-PAGE 
(Figure 3.3). Next, the bioconjugation of the 
mutant GFP protein was examined. The GFP 
containing 11 was reacted with an AlexaFluor-488 alkyne fluorescent dye via a Glaser-
Hay reaction, similar to the one utilized for 5 (Scheme 2.5). Initial attempts at 
bioconjugation failed to couple the two 
molecules, requiring further optimization 
of reaction conditions. The first 
experimental variable assessed was 
temperature, and the reaction was 
incubated at 22° C, a 37° C incubator, and 
at 4° C. Reaction time was also examined, 
as the degradation of protein via copper has 
been previously observed with this 
particular reaction. It was determined by 
SDS-PAGE analysis that a reaction at 4° C 
for 4 hours yielded the bioconjugated 
molecule (Figure 3.4).  
To assess decaging, the protein was subjected to UV irradiation with a 
transilluminator. The protein was irradiated for 10 minutes at a variety of wavelengths. 
Figure 3.4: SDS-PAGE analysis of both the Glaser-Hay bioconjugation and the photoregulation of the conjugate. The top picture is a Coomaise-stained gel, while the bottom picture is a Spyro Ruby fluorescence reading of the gel. Lane 1: Protein Ladder; Lane 2: GFP containing 1 not subjected to Glaser-Hay conditions; Lane 3: GFP containing 1 coupled with AlexaFluor-488 Alkyne, but not irradiated with UV; Lane 4: GFP containing 1 coupled with AlexaFluor-488 Alkyne, and irradiated at 254 nm; Lane 5: Wild-type GFP not irradiated; Lane 6: Wild-type GFP irradiated at 254 nm.Molecular weight is in kDa. 
Lane               1        2        3        4        5         6 GFP                        +1      +1      +1      WT      WT Glaser-Hay              -          +        +        -          -         UV                           -           -        +        -          +        
Figure 3.3: Coomasie-stained SDS-PAGE analysis of GFP containing 11 at residue 151. Some protein is seen in the GFP minus lane due to the promiscuous synthetase incorporating tyrosine. Molecular weight is in kDa. 
Ladder GFP - GFP + 
MW 250 150 100 75 50 37 25 20 15 10 
MW 50  37  25    20  
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Partial decaging was observed after irradiation at 254 nm, but not at higher wavelengths. 
When irradiated at 254 nm for 30 minutes, a greater degree of decaging was observed by 
gel electrophoresis. It was originally hypothesized that decaging would sever the protein 
at the site of UAA incorporation, resulting in two protein fragments (Figure 3.2). However, 
a total protein degradation was observed when analyzed by SDS-PAGE (Figure 3.4). It is 
possible that the streak is due to radicals produced by decaging, which damaged the protein 
as well as proteases, which would cleave the protein. The degradation is not necessarily 
problematic, as if this UAA is coupled to a drug, the drug would have already been 
delivered into the desired location before severing, and would not be affected by the 
proteases. 
Further work will be needed to optimize the decaging of GFP containing 11 in order 
to achieve a greater level of control. The mechanism could be further understood by 
incorporating 11 at different residues of GFP, conjugating to a dye, decaging, and 
observing the bands formed via SDS-PAGE. Also, the decaging conditions need to be 
further optimized, to potentially minimize 
degradation from the high energy UV light. After 
optimization, 11 can be incorporated into an antibody 
and be conjugated by a small drug molecule. 
Antibodies are immune proteins that have two 
variable regions which are highly discriminatory, and 
bind to specific antigens (Figure 3.5).55 The antibody 
can be designed to reach the drug’s target.55 Once at the desired location, the antibody-drug 
complex can be photocleaved, allowing the drug to be released. This would allow less 
Figure 3.5: Structure of an antibody. The variable portions bind with high specificity to particular antigens.55 
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dosage to be utilized, as the drug is carried directly to its target. Also, this methodology 
would be especially beneficial for cancer drugs, as they are expensive to make, and often 
kill non-cancer cells.56 With this strategy, antibodies can be generated that target cells with 
cancer markers, bringing a drug directly to the cancer cells.57 Also, the drug could be 
released at various intervals, depending on the strength of light. Alternatively, caging 
groups that decage at different wavelengths could be synthesized, providing another 
method for controlled drug release.  
Experimental 
General: Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Reactions were conducted 
under ambient atmosphere with non-distilled solvents. Microwave reactions were 
conducted in a CEM Discovery microwave. NMR data was acquired on a Varian Gemini 
400 MHz. Fluorescence data was measured using a PerkinElmer LS 55 Luminescence 
Spectrometer and a Synergy Microplate reader. All GFP proteins were purified according 
to manufacturer’s protocols using a Qiagen Ni-NTA Quik Spin Kit. Glaser-Hay 
deprotection was performed with a VWR UV-AC hand lamp. 
General GFP Expression: A pET-GFP-TAG plasmid (0.5 μL) was co-transformed with 
a pEVOL-tRNA synthetase plasmid (0.5 μL) into Escherichia coli BL21(DE3) cells using 
an Eppendorf eporator electorporator. The cells were then plated (100 μL) on LB agar in 
the presence of chloramphenicol (34 mg/mL) and ampicillin (50 mg/mL) at 37° C 
overnight. One colony was then used to inoculate LB media (4 mL) containing both 
ampicillin and chloramphenicol. The culture was incubated at 37° C overnight and used to 
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inoculate an expression culture (10 mL LB media, 50 mg/mL Amp, 34 mg/mL Chlr) at an 
OD600 0.1. The cultures were incubated at 37° C to an OD600 between 0.6 and 0.8, and 
protein expression was induced by addition of the respective unnatural amino acid (100 
μL, 100 mM) and 20 % arabinose (10 μL) and 0.8 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG; 10 μL). The cultures were incubated at 30° C for 16-20 h 
then pelleted at 5,000 rpm for 10 minutes and stored at -80° C for 3 hours. The cell pellet 
was re-suspended using 500 µL of Bugbuster (Novagen) containing lysozyme, and 
incubated at 37° C for 20 minutes. The solution was transferred to an Eppendorf tube and 
centrifuged at 15,000 rpm for 10 minutes, then the supernatant was added to an equilibrated 
column of Ni-NTA resin (200 µL) and the GFP was purified according to manufacturer’s 
protocol. Purified GFP was analyzed by SDS-PAGE (BioRad 10 % precast gels, 150 V, 
1.5 h), and employed without further purification. 
General aaRS Assessment: The aaRSs were assessed for unnatural amino acid 
incorporation by first co-transforming a pET-GFP-TAG variant plasmid (0.5 μL) with a 
pEVOL-tRNA synthetase plasmid (0.5 μL), in a similar method as described previously. 
For each pEVOL plasmid, one colony was used to inoculate LB media (4 mL) in separate 
containers that contained ampicillin (4 μL, 50 mg/mL) and chloramphenicol (4 μL, 34 
mg/mL). The cultures were incubated at 37° C overnight. Expression cultures were created 
containing LB media (4 mL), ampicillin (4 μL, 50 mg/mL), and chloramphenicol (4 μL, 
34 mg/mL), and then were inoculated with the previous culture (250 μL). The expression 
cultures were incubated at 37° C to an OD600 between 0.6 and 0.8. Protein expression was 
induced by addition of 20 % arabinose (4 μL), and 0.8 mM IPTG (4 μL). The cultures were 
then plated on a 96-well plate (200 μL), with six wells for each plasmid. Three wells were 
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designated as controls, and the other three were designated for the experiment. The 
designated UAA (100 μL, 100 mM) was added to the experimental wells only. The plate 
was allowed to shake at 30° C for 16 h, after which it was measured for fluorescence (528 
nm and 485 nm) utilizing a Synergy HT microplate reader.  
 (3-methoxy-4-(prop-2-yn-l-yloxy)benzaldehyde), 6: The synthesis was conducted using 
literature conditions.53 Vanillin (1.5 g, 9.86 mmol, 1 equivalent) was stirred with Cs2CO3 
(3.213 g, 9.86 mmol, 1 eq) for five minutes in anhydrous DMF (25 mL). To the mixture 
was added propargyl bromide (3.742 mL, 49.3 mmol, 5 equivalents). The reaction was 
stirred at room temperature for 24 hours. The reaction was then quenched with dI H2O (30 
mL) and extracted with EtOAc (3x30 mL) and back extracted with brine (3x80 mL). The 
organic layer was dried with Mg2SO4, filtered, and concentrated by rotatory evaporation. 
The resulting solution was purified via flash chromatography (3:1 Hexanes: EtOAc), 
resulting in a white solid (1.521 g, 8.00 mmol, 81% yield). 
(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)phenyl)methanol, 7: A flask was charged 
with 6 (1.5 g, 8.00 mmol, 1 eq), wrapped in aluminum foil and incubated on ice. Chilled 
HNO3 (50 mL, excess) was added to the flask and allowed to stir for 25 minutes at 0o C. 
The reaction was then warmed to room temperature for 2 hours. The reaction was quenched 
with chilled dI H2O (100 mL) and the precipitate was collected by vacuum filtration and 
washed with ice water (3x30 mL). The resulting product was a yellow solid (1.534 g, 6.52 
mmol, 81% yield) and required no further purification.1H NMR (400MHz; CDCl3): ∂ 10.45 
(s, 1H), 7.79 (s, 1H), 7.43 (s, 1H), 4.90 (s, 2H), 4.02 (s, 3H), 2.62 (s, 1H); 13C NMR 
(400MHz; CDCl3): ∂ 187.9, 153.9, 146.7, 140.2, 126.6, 110.5, 109.6, 78.0, 76.5, 57.4, 57.0. 
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(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)phenyl)methanol, 8: Compound 7 (1.53 g, 
6.52 mmol, 1 eq) was dissolved in EtOH  (120 mL) and wrapped in aluminum foil. NaBH4 
(740 mg, 19.6 mmol, 3 eq) was dissolved in NaOH (50 mL, 1 M). The resulting solution 
was then added to 7 and allowed to stir for 2.5 hours. The reaction was neutralized by HCl 
(50 mL, 1M), and extracted with EtOAc (3x30 mL) and back extracted with brine (3x70 
mL). The organic layer was dried with Mg2SO4 and concentrated using a rotary evaporator. 
The resulting compound was a pale yellow solid (1.78 g, 6.53 mmol, 76% yield) and 
required no further purification. 1H NMR (400MHz; CDCl3): ∂ 7.89 (s, 1H), 7.22 (s, 1H), 
4.98 (s, 2H), 4.84 (s, 2H), 4.01 (s, 3H), 2.58 (s, 1H), 1.56 (s, 1H); 13C NMR (400MHz; 
CDCl3): ∂ 153.9, 146.7, 140.22, 126.6, 111.1, 78.0, 76.5, 63.0, 57.3, 29.9. 
1-(bromomethyl)-5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)benzene, 9: A round 
bottom flask was charged with 8 (1.18 g, 4.96 mmol, 1 equivalent), DCM (40 mL) and  
was wrapped in foil and incubated in an ice bath. PBr3 (1.50 mL, 14.9 mmol, 3 equivalent) 
was added to the reaction vessel and stirred for 6 hours on ice. The reaction was quenched 
with 15 mL of dI H2O, extracted with EtOAc (3x30 mL) and then back extracted with brine 
(3x70 mL). The organic layer was dried with Mg2SO4, filtered, and concentrated via 
rotatory evaporation. The resulting solution was purified by flash chromatography (1:1 
Hexane: EtOAc), yielding a yellow solid (739 mg, 2.46 mmol, 50% yield). 1H NMR 
(400MHz; CDCl3): ∂ 7.85 (s, 1H), 6.98 (s, 1H), 4.87 (s, 2H), 4.84 (s, 2H), 4.01 (s, 3H), 
2.60 (s, 1H), 13C NMR (400MHz; CDCl3): ∂ 153.9, 146.7, 140.2, 128.7, 114.3, 111.3, 57.2, 
56.8, 29.9.  
Diethyl 2-acetamido-2-(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)benzyl)malonate, 
(10): Diethyl acetamidomalonate (106 mg, 0.76 mmol, 2 eq) and Cs2CO3 (114 mg, 0.35 
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mmol, 1 eq) was dissolved in CH3CN (1 mL) for five minutes. Compound 9 (106 mg, 0.35 
mmol, 1 eq) was dissolved in CH3CN (2 mL), and added to the diethyl acetamidomalonate 
solution in a microwave vial. The solution was subjected to microwave irradiation in 
standard mode (130° C, 300W, 10 minutes) and quenched with dI H2O (5 mL). The 
reaction was extracted with ethyl acetate (3x15 mL) and back extracted with brine (3x60 
mL), dried with Mg2SO4, filtered, and concentrated with rotatory evaporation. The 
resulting oil was purified with flash chromatography (1:1 hexanes: EtOAc), yielding a 
peach-colored solid (122 mg, 0.28 mmol, 79% yield). 1H NMR (400MHz; CDCl3): ∂ 7.69 
(s, 1H), 6.76 (s, 1H), 6.52 (s, 1H), 4.80 (s, 2H), 4.33-4.13 (m, 4H), 4.10 (s, 3H), 3.90 (s, 
2H), 2.59 (s, 1H), 1.94 (s, 3H), 1.29 (t, J = 7.2, 6H); 13C NMR (400MHz; CDCl3): ∂ 169.7, 
167.8, 152.9, 145.7, 142.1, 126.1, 116.0, 115.9, 78.0, 76.6, 66.1, 63.0, 57.1, 56.5, 35.2, 
14.0, 14.0. 
1-carboxy-2-(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)phenyl)ethan-1-aminium, 
(11): Compound 10 (96.3 mg, 0.22 mmol, 1 eq) was stirred with 6N HCl (3 mL) under 
microwave irradiation in standard mode (90° C, 300W, 10 mins). The reaction was 
concentrated by rotatory evaporation, yielding a white solid (62 mg, 0.21 mmol, 95% 
yield). 1H NMR (400MHz; CDCl3): ∂7.88 (s, 1H), 7.11 (s, 1H), 4.86 (d, J=6 Hz, 2H), 4.38-
4.31 (m, 1H), 3.78 (s, 3H), 3.76-3.70 (m, 1H), 3.43-3.33 (m, 1H), 3.05 (s, 1H); 13C NMR 
(400 MHZ; CD3OD): δ 169.8, 168.3, 152.4, 146.3, 141.5, 122.9, 114.9, 112.1, 76.4, 56.1, 
53.1, 39.7, 34.1 
Glaser-Hay Bioconjugation and Decaging: GFP containing 11 at residue 151 (20 μl), 
AlexaFluor-488 Alkyne (15 μl, 1 mM), CuI (5 μl, 50mM), and tetramethylethylenediamine 
(5 μl, 50 mM) were added to an Eppendorf tube. A control reaction omitting the CuI and 
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TMEDA was conducted simultaneously. The tubes were incubated at 4° C for 4 hours. In 
order to remove excess copper and fluorophore, a buffer exchange was performed with 
Spin-X UF concentrator columns, and with PBS (8x200 μL) to a final volume of 50 μL. 
The GFP was analyzed by SDS-PAGE (BioRad 10 % precast gels, 150 V, 1.5 h). Gels 
were imaged on a BioRad Molecular Imager (Gel Doc XR+), first via a Spyro Ruby 
irradiation to analyze fluorescence. Then, the gel was stained with Coomasie Brilliant Blue 
for an hour. The gel was then destained utilizing destain solution (60 % deionized water, 
30 % methanol, 10 % acetic acid) until the gel was clear, after which the gel was analyzed 
via the Coomasie protocol on the BioRad Molecular Imager.for protein via the Coomasie 
setting on the BioRad Molecular Imager. 
Decaging of GFP was achieved by transferring the conjugated GFP containing 11 
Glaser-Hay (15 μL) in a clear eppendorf tube. A control was made by adding GFP wild 
type (15 μL) to a clear Eppendorf tube. Both tubes were irradiated at 254 nm for 30 mins 
using a VWR UV-AC hand lamp. The GFP was analyzed by SDS-PAGE (BioRad 10 % 
precast gels, 150 V, 1.5 h). Gels were imaged on a BioRad Molecular Imager (Gel Doc 
XR+), first via a Spyro Ruby irradiation to analyze fluorescence. Then, the gel was stained 
with Coomasie Brilliant Blue for an hour. The gel was then destained utilizing destain 
solution (60 % deionized water, 30 % methanol, 10 % acetic acid) until the gel was clear, 
after which the gel was analyzed via the Coomasie protocol on the BioRad Molecular 
Imager. 
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Scheme 4.260 
 
 
Chapter 4: A Copper-Free Microwave 1,3-Dipolar 
Cycloaddition System 
 
1,3-Dipolar Cycloadditions are highly selective reactions between alkyne and azide 
functional groups. First characterized by Rolf Huisgen in 1963, his conditions generated 
both the 1,4 and 1,5 adducts when reacted at 98° C for 18 hours (Scheme 4.1).58 Sharpless 
later improved the reaction  
by adding a copper catalyst, 
enhancing the reaction rate 
and exclusively generating 
the 1,4 isomer (Scheme 4.2).59,60 The utility of this reaction is highlighted by its use in 
complex biological systems, with relatively high specificity.  Applications include its use 
to design HIV protease inhibitors, in vivo fluorescence labeling, creating new drugs, linking 
proteins together, and cell and protein 
immobilization.61 Click chemistry has 
additionally been coupled with microwave 
technology to achieve great yields with 
regioselectivity, in a matter of minutes.62  
 One problem associated with utilizing this reaction in biological environments is 
the toxicity associated with copper ions. Copper (II) ions react with hydrogen peroxide to 
Scheme 4.1 
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form a hydroxyl radical, which is a very powerful oxidizing agent. It has been shown to 
oxidize proteins and DNA, and disrupt the intermolecular interactions essential within 
large biomolecules.63 Copper (II) protein degradation has also been associated with 
diabetes and aging via autoxidative glycosylation64, as well as degradation of albumin.65  
 Copper-free [3+2] cycloadditions between azides and acyclic alkynes have been 
demonstrated in cyclooctynes66 and  activated oxanorbornadienes67. Other researchers have 
utilized inverse-electron-demand Diels-Alder reactions to attach trans-cyclooctene 
compounds to a bipydridyltetrazine-tethered probe.68 Also, photoinducible dipolar 
cycloadditions (photo-click reactions) between nitrile imines and alkenes have been 
examined.69 These reactions however, take advantage of ring strain, and often require 
synthesizing complicated cyclic molecules, in the case of the [3+2] cycloadditions, or 
require photo-reactive molecules such as tetrazoles, in the case of the photo-click 
reactions.70 We seek to develop a method to undergo copper-free 1,3-dipolar 
cycloadditions between alkynes and azides, regardless of structure, in high yield. 
Results and Discussion: 
The optimized microwave-mediated 1,3 dipolarcycloaddition required many trials 
altering microwave conditions, and required substantial troubleshooting of separation and 
purification techniques. Proof-of-concept experiments were peformed using benzyl azide 
(21 μL, 0.17 mmol, 1 equiv.) and phenylactylene (18.6 μL, 0.17 mmol, 1 equivalent), as 
well as identical amounts of deionized water, tBuOH, and TCEP (Scheme 4.3) similar to 
literature conditions. Note 
that copper was not used as a Scheme 4.3 
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reagent for these reactions. After microwave irradiation, the reaction was extracted in ethyl 
acetate and brine; however, it was theorized that the miscibility of tBuOH could leave the 
click products in the aqueous layer, reducing the experimental yield, and forcing an 
evaluation of organic extraction solvents. Extracting the reaction in dichloromethane 
produced similar yields, as ethyl acetate. Consequently, the solvent was then immediately 
removed after microwave irradiation by rotary evaporation, to remove both water and 
tBuOH, and then subjected to flash chromatography. This proved to afford a higher yield, 
and thus was adopted as a general protocol for all additional reactions.  
  The microwave reaction was first attempted at 100 W, 100° C, for 10 mins on 
temperature mode, generating a poor yield of 21.9 %. However, a control reaction of 
phenylacetylene and benzyl azide in a 100° C oil bath resulted in an extremely low yield 
(less than 5 %), representing some advantage of the microwave. The temperature was 
raised to 125° C with the same conditions, resulting in a slightly higher yield of 26.0 %. 
Reaction time was then increased to 20 mins (at 100 W and 125° C), with yet another slight 
increase in yield of 31.4 %. Further attempts to increase temperature and time resulted in 
no significant improvement in yield. The reaction was then attempted in the power mode 
setting, which applies a constant power while allowing the temperature to fluctuate unless 
it achieves a certain limit at which the reaction is halted, which in this case was 168° C. 
Attempting this at 100 W and 200 W resulted in yields of 23.0 % and 26.0 % respectively. 
Interestingly, increasing the power to 300 W resulted in a significant increase in yield to 
49.2 %, despite the reaction only proceeding for 1 minute. To probe deeper, the reaction 
was run twice at 300 W, resulting in a significantly lower yield of 21.9 %. This decreased 
yield could be due to extreme conditions that decomposed the reagents or the click product.  
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 Another microwave procedure was investigated in order to generate higher yields. 
The peptide synthesis (SPS) procedure irradiates at a constant power until it reaches a 
specific temperature, where it then stops irradiation until the temperature drops to an 
acceptable range, and then it irradiates again. This cycle occurs for a set amount of time. 
For the click reactions, the maximum temperature was set to 168° C, the temperature at 
which irradiation again proceeds (denoted as ݀ܶ) was set for 15° C, and the total time was 
set for 20 minutes. This procedure has an advantage that it is able to irradiate at high power 
for a much longer length of time than power mode. Irradiation at 200 W on SPS mode 
resulted in a 48.1 % yield, while irradiation at 300 W on SPS mode resulted in a very high 
yield of 96.2 %. When performing a similar microwave reaction in the presence of a copper 
sulfate catalyst at 300 W on SPS mode, a similar yield was recorded. 
 Having obtained optimized reaction conditions, a series of azides and alkynes were 
examined utilizing the 300W SPS mode in order to elucidate the scope of the reaction 
(Table 4.1). It was determined that using a long aliphatic azide significantly reduced yield, 
regardless of the structure of the alkyne. Azidoheptane was reacted with phenylacetylene, 
1-hexyne, and propargyl alcohol, producing yields of 19.3%, 15.8 %, and 14.5 % 
respectively. It was originally theorized that long chained aliphatic azides may not be well 
suited for the water and tBuOH solvents, or that they were microwave transparent as they 
possess very small dipoles. Therefore, to investigate the microwave suitability of nonpolar 
hydrocarbons, 1-hexyne was utilized as the alkyne reactant, undergoing reactions with 
benzyl azide and trimethylsilyl azide, and generating yields of 96.8 % and 37.6 % 
respectively. It should be noted that when using trimethylsilyl azide as a reactant, NMR of 
the click product indicated a TMS group; however, the acidity of the silica gel from flash  
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Table 4.1: A series of azides and alkynes were experimented using the SPS copper-free method. Note that the yields for compounds 26-28 represent the cleaved resin product (see experimental section). 
 
 
 
  
  12 96.2 %  
 13 19.3 % 
 
 14 64.8 % 
 
 15 96.8 %  
 16 15.8 %  
 17 37.6 %  
 
  18 <5 % 
  19 <5 % 
  20 <5 %  
  21 
 22 14.7 % 23 10.7 % 
 24 12.1 % 
  25  26 75.5 %  
 27 63.4 % 
 28 81.3 % 
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chromatography cleaved the TMS group. The higher yields, especially with benzyl azide, 
create a more complex dynamic regarding the suitability of aliphatic hydrocarbons. It 
appears that aliphatic azides produce much lower yields, and the nature of the hydrocarbon 
chain of the alkyne molecule is somewhat independent of the yield. Moreover, it suggests 
that the aliphatic azide may simply be less stable under microwave irradiation and prone 
to degradation, resulting in decreased yields; however, this premise needs further testing. 
Reactions with polar alkynes also failed to produce the desired products in 
appreciable yields. Propargyl alcohol was reacted with benzyl azide, azidoheptane, and 
trimethylsilyl azide, resulting in yields of less than 5 %. The most striking observation is 
that the reaction with benzyl azide resulted in a low yield, as the previous benzyl azide 
reactions with phenylacetylene and 1-hexyne have yields of 96.2 % and 96.8 % 
respectively. Propargyl alcohol was then protected with trityl chloride, to see if a protected 
alcohol would generate higher yields (Scheme 4.4). Fortunately, yields improved to 10-15 
%, indicating that perhaps more non-polar molecules will react at higher yields.  
 
 
 
  
Propargyl alcohol was then immobilized on a solid-supported resin to potentially 
confer higher microwave stability (Scheme 4.5). The protected alkyne was then reacted 
under similar microwave conditions with benzyl azide, azidoheptane, and trimethylsilyl 
azide, and then deprotected. Gratifyingly, the yields were much higher in generating the 
Scheme 4.4 
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propargyl alcohol click product, around 60 – 70 %. Unfortunately, due to the nature of the 
solid support, only 1 – 2 mgs, of product was obtained, making the determination of exact 
yields difficult to obtain. However, NMR spectra confirmed the presence of the product in 
high purity. 
 
  
 
To further probe the scope of this methodology, a series of molecularly distinct 
azides were examined with the same series of alkynes (Figure 4.1). The first azide 
investigated was 4-azidobenzoic acid (29), a highly polar azide to compare to the 
previously non-polar substates. Utilizing the 300 W SPS conditions, very little product was 
obtained for any of the reactions, and the click products were unable to be separated via 
flash chromatography. One explanation for the poor yields could be that 4-azidobenzoic 
acid is an unstable molecule, and the microwave irradiation decomposed the reactant or 
click product. When reacted on power mode at various powers, similar low yields were 
observed. Two unnatural amino acid azide molecules were then tested under microwave 
conditions. The para-
azidophenylalanine (30) 
unnatural amino was not 
able to successfully react 
with any of the previous 
Figure 4.1: Three molecularly distinct azides tested for their propensity to undergo copper-free click reactions. 29 is commercially available azidobenzoic acid, 30 is protected para-azidophenylalanine, 31 is a protected tyrosine tethered azide. 
Scheme 4.5 
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alkynes. This could be due to the nature of the aromatic azide providing unfavorable steric 
and electronic conditions for the reaction. To account for sterics, a protected C4 tethered 
azido tyrosine unnatural amino acid (31) was also utilized. However, no product was 
obtained when reacted with any alkyne. Although further tests need to be performed, polar 
molecules appear not to be able to undergo copper-free click reactions. This would explain 
the inability of the two unnatural amino acids to react, as the carboxyl C-terminus is 
extremely polar. 
 One of the more intriguing aspects of the microwave copper-free click chemistry 
was the ratio of 1,4 and 1,5 adducts. When copper sulfate was included in the microwave 
conditions, all reactions produced the 1,4 adduct. Without copper sulfate however, the ratio 
of adducts becomes complex. For example, when reacting benzyl azide, azidoheptane, and 
TMS-azide, with 1-hexyne, the respective ratio of 1,4 adducts to 1,5 adducts was 1:6, 1:1.7, 
and 3:1. Interestingly, when reacting the above azides with the resin protected propargyl 
alcohol, the ratios for the three click products were 1:3, in favor of the 1,5 adduct. For this 
particular example, it’s possible that there is steric hindrance for the 1,4 position to form 
due to the triphenyl groups; however, the chemical properties of the azide did not affect 
the ratio. 
 In conclusion, it was demonstrated that microwave copper-free click chemistry is 
feasible, and can occur with high yields. Further investigation is needed to understand the 
molecular characteristics that control the reaction in the absence of copper catalysts. A 
range of polar azides and alkynes will need to be examined, in order to optimize polar 
microwave click reactions. These conditions include altering the cycle temperature range 
(dT), reacting at different equivalents of alkynes and azides, and utilizing different solvents. 
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However, immobilizing polar compounds onto a solid-supported resin is an effective 
solution, as demonstrated from the high yields obtained from the immobilized propargyl 
alcohol. Also, similar experiments are needed to understand the conditions needed to obtain 
regioselectivity in the reactions. 
Copper-free clicks are especially relevant in vivo, as copper has been demonstrated 
to aid in radical formation and protein degradation. Click chemistry is an important tool 
for bioconjugation, and the ability to click without cytotoxic copper would allow for safer 
click bioconjugation in living cells. However, one important factor is that proteins (and 
living cells) are not viable in microwaves, as protein degrades under the high temperature. 
Currently, we are working on adapting these conditions to proteins by conducting the 
reaction at much lower temperatures, as will be described in the next chapter. Moreover, 
microwave copper-free Cadiot-Chodkiewicz and Glaser-Hay couplings are also being 
explored.  
Experimental: 
General: Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Reactions were conducted 
using a CEM Discovery Microwave. NMR data was acquired on a Varian Gemini 400 
MHz. GC/MS analysis was conducted on an Agilent Technologies 6890N GC system 
interfaced with a 5973N mass selective detector. An Agilent J&W GC capillary column 
(30 m length, 0.32 mm diameter, 0.25 m film) was employed with a splitless injection 
(250° C inlet, 8.8 psi) with an initial 70 oC hold (2 min) and ramped for 15 min to 230° C. 
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General 1,3-dipolar Cycloaddition Method: To a microwave vial was added a small 
stir bar, an alkyne (1.7x10-4 moles; 1 eq.), an azide (1.7x10-4 moles; 1 eq.), tris(2-
carboxyethyl)phosphine (TCEP; 50 mmol, 32μL), deionized water (970 μL), and tert-
Butyl alcohol (99 %, 1 mL).  The solution was subjected to microwave irradiation (SPS 
mode, 20 minutes, 0-300 W, 168° C, δT= 15° C). The resulting mixture was then 
quenched with chilled dI water (10 mL, 0° C). A rotary evaporator was used to remove 
water from the reaction, and the crude product was purified using flash chromatography 
(3:1 hexanes:EtOAc) to yield the product. 
1-benzyl-4-phenyl-1H-1,2,3-triazole, 12: The solvent was removed in vacuo to give 12 
as a solid (38 mg, 0.162 mmol, 96.2 %) 1H NMR (400 MHz; CDCl3): ∂ 7.798 (dd, J=8.4 
Hz, 2H), 7.744 (s, 1H), 7.661 (s, 1H), 7.445-7.365 (m, 3H), 7.334-7.240 (m, 4H), 7.085-
7.062 (m, 2H), 5.581 (s, 2H), 5.548 (s, 2H); 13C NMR (400 MHz; CDCl3): ∂ 135.489, 
133.289, 129.510, 129.160, 128.948, 128.895, 128.827, 128.796, 128.151, 127.150, 
125.693, 119.470, 54.240, 51.804; GCMS (Rt = 12.54) calculated for C15H13N3 235.29, 
found 235.2. Regioisomer ratio of 1,4:1,5 adducts was found to be 1.1:1. 
1-heptyl-4-phenyl-1H-1,2,3-triazole, 13: The solvent was removed in vacuo to give 13 
as a solid (8 mg, 0.033 mmol, 19.3 %) 1H NMR (400 MHz; CDCl3): ∂ 7.834 (dd, J=8.45 
Hz, 2H), 7.738 (s, 1H), 7.688 (s, 1H), 7.502-7.366 (m, 3H), 4.398 (t, 2H), 4.336 (t, 2H), 
1.929 (quintet, 2H), 1.817 (quintet 2H), 1.373-1.165 (m; 8H), 0.896-0.824 (m, 3H); 13C 
NMR (400 MHz, CDCl3): ∂ 129.358, 129.047, 128.751, 125.685, 48.291, 31.475, 30.071, 
28.523, 26.352, 22.452, 13.961; GCMS (Rt = 13.77 min) calculated for C15H21N3 243.35, 
found 243.2. Regioisomer ratio of 1,4:1,5 adducts was found to be 2:1 
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4-phenyl-1H-1,2,3-triazole, 14: The solvent was removed in vacuo to give 14 as a solid 
(16 mg, 0.110 mmol, 64.8 %) 1H NMR (400 MHz; CDCl3): ∂ 7.976 (s, 1H), 7.826 (d, 
2H), 7.479-7.367 (m, 3H); 13C NMR (400 MHz; CDCl3): ∂ 128.971, 128.773, 126.110; 
GCMS (Rt= 8.71 min) calculated for C8H7N3 145.16, found 145.1. Regioisomer ratio of 
1,4:1,5 adducts was found to be 1:1.2 
1-benzyl-4-butyl-1H-1,2,3-triazole, 15: The solvent was removed in vacuo to give 15 as 
a solid (35 mg, 0.163 mmol, 96.8 %) 1H NMR (400 MHz; CDCl3): ∂ 7.939 (s, 1H), 
7.405-7.388 (m, 2H), 7.378-7.263 (m, 3H), 5.560 (s, 2H), 3.090 (t, 2H), 1.767 (q, 2H), 
0.995 (3, 2H), 0.914 (q, 3H); 13C NMR (400 MHz; CDCl3): ∂ 129.335, 129.183, 128.349, 
125.230, 54.475, 41.400, 17.413, 13.801; GCMS (Rt = 11.67 min) calculated for 
C13H17N3 215.30, found 215.2. Regioisomer ratio of 1,4:1,5 adducts was found to be 1:6. 
4-butyl-1-heptyl-1H-1,2,3-triazole, 16: The solvent was removed in vacuo to give 16 as 
a solid (6 mg, 0.027 mmol, 15.8 %) 1H NMR (400 MHz; CDCl3): ∂ 7.729-7.698 (m, 1H), 
7.542-7.520 (m, 1H), 4.297 (t, 2H), 4.235 (t, 2H), 1.721 (quintet, 2H), 1.413-1.259 (m, 
14H), 0.988-0.849 (m, 6H); 13C NMR (400 MHz; CDCl3): ∂ 130.883, 128.827, 65.865, 
29.282, 28.917, 28.538, 25.950, 25.609, 23.742, 22.520, 14.021;GCMS (Rt = 10.49 min) 
calculated for C13H25N3 223.36, found 223.2. Regioisomer ratio of 1,4:1,5 adducts was 
found to be 1:1.7. 
4-butyl-1H-1,2,3-triazole, 17: The solvent was removed in vacuo to give 17 as a solid (8 
mg, 0.064 mmol, 37.6 %) 1H NMR (400 MHz; CDCl3): ∂ 8.183 (s, 1H), 3.042 (t, 2H), 
1.838-1.683 (m, 4H), 1.012 (t, 2H); GCMS (Rt = 8.78 min) calculated for C6H11N3 
125.18, found 125.1. Regioisomer ratio of 1,4:1,5 adducts was found to be 3:1. 
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 ((prop-2-yn-1-yloxy)methanetriyl)tribenzene, 21: To a flame dried vial was added 
(chloromethanetriyl)tribenzene (250 mgs, 0.90 mmol, 1.0 equiv.), propargyl alcohol (76 
μL, 1.31 mmol, 1.5 equiv.), and triethylamine (TEA; 624 μL). The reaction was allowed 
to stir at room temperature for 2 days. The product was extracted with dichloromethane 
(3 x 20 mL), and the organic layer was then back-extracted with brine (3 x 30 mL). The 
organic layer was then isolated, dried with MgSO4, filtered, and the solvent was removed 
by rotatory evaporation.  The product was purified via flash chromatography with a 3:1 
hexanes/ethyl acetate eluent, and the solvent was removed in vacuo to give 21 as a solid 
(243 mgs, 8.14x10-4 mol, 90.7 %)  1H NMR (400 MHz; CDCl3): ∂ 7.536 (2, 4H), 7.371-
7.261 (m, 20H), 3.811 (d, J=2.8 Hz, 2H), 2.866 (s, 1H). 
1-benzyl-4-(trityloxy)-1H-1,2,3-triazole, 22: The solvent was removed in vacuo to give 
22 as a solid (10 mg, 2.33x10-5 mol, 13.7 %). 1H NMR (400 MHz; CDCl3): ∂ 7.564 (s, 
1H), 7.478 (d, 4H), 7.472-7.177 (m, 16 H), 6.987-6.965 (m, 4H), 5.522 (s, 2H), 5.495 (s, 
2H), 4.309 (s, 2H), 4.083 (s, 2H). 
1-heptyl-4-(trityloxy)-1H-1,2,3-triazole, 23: The solvent was removed in vacuo to give 
23 as a solid (8 mg, 1.82x10-5, 10.7 %). 1H NMR (400 MHz; CDCl3): ∂ 7.546 (s, 1H), 
7.471-7.440 (m, 5H), 7.351-7.260 (m, 10H), 4.189 (s, 2H), 4.163 (t, 2H), 1.763 (quintet, 
2H), 1.254-1.198 (m, 8H), 0.853 (t, 3H). 
4-(trityloxy)-1H-1,2,3-triazole, 24: The solvent was removed in vacuo to give 24 as a 
solid (7 mg, 2.06x10-5 mol, 12.1 %). 1H NMR (400 MHz; CDCl3): ∂ 7.605 (d, 2H), 7.585 
(d, 2H), 7.547 (d, 4H), 7.342-7.230 (m, 10 H), 3.758 (s, 2H), 3.725 (s, 2H). 
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Immobilization of Propargyl Alcohol onto Trityl Chloride Resin in Low Loading, 25: 
To flame dried vial was added trityl chloride resin (200 mg, 0.36 mmol, 1 equiv.) and 
dichloromethane (5 mL). The resin was swelled at room temperature with gentle stirring 
for 15 min. Propargyl alcohol (25.0 µL, 0.433 mmol, 1.2 equiv.) was added to reaction, 
followed by triethylamine (10.0 µL, 0.072 mmol, 0.2 equiv). The mixture was stirred at 
room temperature for 16 h. The resin was transferred to a syringe filter and washed with 
DCM and MeOH (5 alternating rinses with 5 mL each). The resin was swelled in DCM 
and dried under vacuum for 45 min before further use. 
Microwave Click using Solid-Support Propargyl Alcohol: To a microwave vial was 
added 25 (40 mgs, 7.2x10-6 mol, 1 equiv.), an azide (7.2x10-5 mol, 10 equiv.), tris(2-
carboxyethyl)phosphine (TCEP; 50 mmol, 32μL), deionized water (970 μL), and tert-Butyl 
alcohol (99 %, 1 mL).  The solution was subjected to microwave irradiation (SPS mode, 
20 minutes, 0-300 W, 168° C, δT= 15° C). The resulting mixture was quenched with chilled 
deionized water (5 mL, 0° C). The resin was transferred to a syringe filter and washed with 
DCM and MeOH (5 alternating rinses with 5 mL each).  
Compound 26: Compound 26 was then cleaved from the resin by treatment with 2 % TFA 
(DCM, 1 h), and filtered into a vial. A short silica plug was then employed to remove 
unreacted starting material (1:1 EtOAc/Hex). The solvent was removed in vacuo to give 
17 as a solid (1.0 mg, 5.28x10-6 mol, 73.5 %). 1H NMR (400 MHz; CDCl3): ∂ 7.414-7.241 
(m, 5H), 5.658 (s, 2H), 5.532 (s, 2H), 5.313 (s, 1H), 4.752 (s, 2H), 4.610 (s, 2H); 13C NMR 
(400 MHz; CDCl3): ∂ 147.266, 129.327, 129.214, 129.115, 128.736, 128.295, 127.635, 
122.225, 55.348, 54.847, 53.291, 52.730, 29.699; GCMS (Rt = 10.84 min) calculated for 
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C10H11N3O 189.22, found at 189.2. Regioisomer ratio of 1,4:1,5 adducts was found to be 
1:3. 
Compound 27: Compound 27 was then cleaved from the resin by treatment with 2 % TFA 
(DCM, 1 h), and filtered into a vial. A short silica plug was then employed to remove 
unreacted starting material (1:1 EtOAc/Hex). The solvent was removed in vacuo to give 
18 as a solid (0.9 mg, 4.56x10-6 mol, 63.4 %). 1H NMR (400 MHz; CDCl3): ∂ 7.684 (s, 
1H), 7.578 (s, 1H), 5.486 (s, 1H), 4.788 (d, J=4 Hz, 2H), 4.418-4.352 (m, 2H), 1.930 
(quintet, 2H), 1.346-1.250 (m, 8H), 0.895-0.860 (m, 3H); 13C NMR (400 MHz; CDCl3): ∂ 
122.172, 55.302, 53.253, 51.106, 31.558, 31.497, 30.078, 28.674, 28.576, 26.512, 26.345, 
22.490, 13.991; GCMS (Rt = 11.72) calculated for C10H19N3O 197.28, found 196.2. 
Regioisomer ratio of 1,4:1,5 adducts was found to be 1:3. 
Compound 28: Compound 28 was then cleaved from the resin by treatment with 2 % TFA 
(DCM, 1 h), and filtered into a vial. A short silica plug was then employed to remove 
unreacted starting material (1:1 EtOAc/Hex). The solvent was removed in vacuo to give 
19 as a solid (1.0 mg, 5.84x10 -6 mol, 81.3 %). 1H NMR (400 MHz; CDCl3): ∂ 7.637 (s, 
1H), 7.519 (s, 1H), 4.804 (s, 2H); GCMS (Rt = 10.84 min) calculated for C6H13N3OSi 
171.28, found 171.1. Regioisomer ratio of 1,4:1,5 adducts was found to be 1:3. 
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Chapter 5: Developing Microwave Bioconjugations via 
CoolMate Technology  
 Microwave technology offers a fast and efficient method for chemical synthesis; 
however, it is not applicable for most biological applications, especially in vivo. This is 
because microwave irradiation results in extremely high localized temperatures, often 
exceeding 100° C. In humans, physiological temperature is at 37° C, and when this 
temperature is even moderately altered, macromolecules 
such as proteins and DNA begin to denature, and are no 
longer viable.1,2 Despite this fact, some thermophilic 
enzymes, such as AdoHyc hydrolase and MTA 
phosphorylase from S. solfataricus, are able to withstand 
temperatures up to 90° C, and have been investigated in 
a microwave setting.71 One alternative method to 
utilizing microwave irradiation for biological molecules 
is via a CoolMate apparatus (Figure 5.1).72 The Coolmate 
allows solutions to reach temperatures of -20° C to -30° 
C, affording microwave irradiation to be applied, and stopped once the temperature reaches 
physiological temperature.72 CoolMate technology has been applied to the synthesis of 
organic molecules, such as diphenoxybutene and phenoxydiene.73 
 As previously mentioned, bioconjugation offers a unique method to append certain 
molecular moieties, such as dyes, and other substrates to proteins.45-49 Microwave 
irradiation could offer a quick method to facilitate bioconjugation reactions with proteins, 
Figure 5.1: Diagram of a CoolMate vessel. A vial is kept cooled via a cooling medium, while simultaneously receiving microwaving irradiation.72 
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as often these bioconjugation reactions can take many hours.44,45 Also, bioconjugation 
reactions such as 1,3-dipolar cycloadditions utilize metals, which degrade the biomolecules 
the longer the reaction occurs.  Through CoolMate technology, proteins can be efficiently 
conjugated using microwave irradiation, without 
thermal degradation. Moreover, due to the 
accelerated rate of the reaction, less protein would 
be degraded by catalytic metals. Two unnatural 
amino acids were examined for their abilities to 
undergo bioconjguations with dyes via both 
Glaser-Hay and 1,3-dipolar cycloaddition reactions under CoolMate conditions (Figure 
5.2). UAA 30 and 32 both contain reactive moieties that allow them to react under 
physiological conditions, depending on the respective dye substrates.  
Results and Discussion: 
 Initial attempts at bioconjugation suffered from a lack of reproducibility. Both 
UAA 30 and 32 were investigated for their ability to undergo a click reaction with an alkyne 
or azide Alexafluor dye, respectively (Scheme 5.1). It was determined that only GFP 
containing UAA 32 was able to undergo click reactions. This is may be due to sterics, as 
the azide group is in close 
proximity to the benzene 
ring on UAA 30, and thus 
closer to the bulk of the 
protein. UAA 32 has a 
methylene extension from 
[Grab your reader’s attention with a great quote from the 
document or use this space to emphasize a key point. To 
place this text box anywhere on the page, just drag it.] 
200 W x2 300 W 200 W x2 300 W A) B) 
Figure 5.3: SDS-PAGE analysis of CoolMate clicks with GFP containing 32. A) Fluorescence readings. Since there are fluorescent bands, it indicates that the protein has bioconjugated with the fluorescent dye. B) Coomasie stained gel, showing protein.  
Figure 5.2: Two UAAs being tested for bioconjugation under CoolMate conditions. UAA 30 contains an azide moiety, while UAA 32 contains an alkyne moiety. 
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the aromatic ring, which reduces some of the steric bulk. Preliminary reactions were 
performed using 1 mL of deionized water and 1 mL of tBuOH, but it was later discovered 
that reducing the concentrations to 500 μL of deionized water and 500 μL tBuOH resulted 
in higher yields of click product. This is due to an increased concentration increasing the 
propensity of the two reaction partners to react with appropriate orientations. The 1,3-
dipolar cycloaddition reactions were examined at various power settings, and it was 
determined that reacting twice at 200 W and once at 300 W for 5 minutes (or when the 
reaction reached 40° C)  yielded the best results (Figure 5.3). Unfortunately, these results 
have been very difficult to reproduce. This could be due to the fact that large amounts of 
protein are needed, and to repeat the process, additional GFP containing UAA 32 needs to 
be expressed and concentrated. The new expressions are often at differing concentrations, 
so is possible that a certain concentration of GFP is needed for the reaction to proceed. 
 
Scheme 5.174 
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 GFP containing UAA 32 was also reacted with an alkyne dye, in order to test 
Glaser-Hay bioconjugation reactions under CoolMate conditions (Scheme 5.2). Similar to 
the click conditions, the volume of water was reduced from 2 mL to 1 mL, in order to 
increase the propensity of 
the two reaction partners 
to react with appropriate 
orientations. Various pow-
er settings were tested for 
the Glaser-Hay reaction, 
and it was found that undergoing the reaction at 200 W twice for 5 minutes (or until the 
reaction reached 40° C), afforded bioconjugation product. Interestingly, it was also 
demonstrated that in the absence of copper iodide, Glaser-Hay product was still able to be 
formed (Figure 5.4). However, similar to the click bioconjugations, this procedure has poor 
reproducibility, and it is also theorized to be a result of inconsistency in protein expression.  
 
 
 
 Despite the difficulties with reproducibility, preliminary results indicate the success 
of both bioconjugation methods. This is the first known successful bioconjugations of 
 
Scheme 5.274 
A) B) Ladder 
GH - GH + GH -  GH + 
Figure 5.4: SDS-PAGE analysis of CoolMate Glaser-Hay with GFP containing 32. A) Fluorescence readings. The GH + band indicates that the Glaser-Hay bioconjugation was successful as the fluorescent dye appears. Interestingly, the control (GH-) lane also shows a faint band, indicating that the Glaser-Hay reaction occurred without catalyst. B) Coomasie stained gel, showing protein. 
MW 250 150 100 75 50 37 25 20 15 10 
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proteins utilizing microwave irradiation. Both bioconjugation reactions take less than five 
minutes to complete, which allows for a more efficient reaction. In the case of the click 
reactions, this means that there is less time for the protein to degrade from the copper (II) 
ions. In the case of the Glaser-Hay reactions, the success of the control indicates that the 
microwave irradiation provides enough energy to facilitate the reaction, even in the absence 
of copper. Both bioconjugation reactions are currently being optimized, in order to both 
improve reproducibility, and make the reaction more efficient. Also, the copper-free 
Glaser-Hay bioconjugation is also being optimized, in order to increase yields, and make 
the reaction viable for broader applications. 
Experimental: 
General: Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Microwave reactions were 
conducted in a CEM Discovery microwave and CEM Discovery CoolMate microwave. 
NMR data was acquired on a Varian Gemini 400 MHz. All GFP proteins were purified 
according to manufacturer’s protocols using a Qiagen Ni-NTA Quik Spin Kit.  
General GFP Expression: A pET-GFP-TAG plasmid (0.5 μL) was co-transformed with 
a pEVOL-tRNA synthetase plasmid (0.5 μL) into Escherichia coli BL21(DE3) cells using 
an Eppendorf eporator electorporator. The cells were then plated (100 μL) on LB agar in 
the presence of chloramphenicol (34 mg/mL) and ampicillin (50 mg/mL) at 37° C 
overnight. One colony was then used to inoculate LB media (4 mL) containing both 
ampicillin and chloramphenicol. The culture was incubated at 37° C overnight and used to 
inoculate an expression culture (10 mL LB media, 50 mg/mL Amp, 34 mg/mL Chlr) at an 
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OD600 0.1. The cultures were incubated at 37° C to an OD600 between 0.6 and 0.8, and 
protein expression was induced by addition of the respective unnatural amino acid (100 
μL, 100 mM) and 20 % arabinose (10 μL) and 0.8 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG; 10 μL). The cultures were incubated at 30° C for 16-20 h 
then pelleted at 5,000 rpm for 10 minutes and stored at -80° C for 3 hours. The cell pellet 
was re-suspended using 500 µL of Bugbuster (Novagen) containing lysozyme, and 
incubated at 37° C for 20 minutes. The solution was transferred to an Eppendorf tube and 
centrifuged at 15,000 rpm for 10 minutes, then the supernatant was added to an equilibrated 
column of Ni-NTA resin (200 µL) and the GFP was purified according to manufacturer’s 
protocol. Purified GFP was analyzed by SDS-PAGE (BioRad 10 % precast gels, 150 V, 
1.5 h), and employed without further purification. Gels were imaged on a BioRad 
Molecular Imager (Gel Doc XR+), after being stained with Coomasie Brilliant Blue for an 
hour. The gel was then destained utilizing destain solution (60 % deionized water, 30 % 
methanol, 10 % acetic acid) until the gel was clear, after which the gel was analyzed via 
the Coomasie protocol on the BioRad Molecular Imager. 
Coolmate Click Procedure: GFP containing 30 or 32 at residue 151 (30 μl), AlexaFluor-
488 dye (20 μl, 1 mM), deionized water (500 μL), tris(2-carboxyethyl)phosphine (TCEP; 
32 μL, 50 mM), CuSO4 (32 μl, 50mM), tert-Butyl alcohol (99%, 500 μL), and a stir bar 
were added to a Coolmate vial. Perfluoro polyether was added to a CEM Discover 
Coolmate. Liquid nitrogen or dry ice was added to the cooling chambers, to cool the 
Coolmate to -50° C. The flow rate was turned on to a moderate to high level, and the 
contents of the vial were cooled to -30° C and subjected to microwave irradiation (200 W 
or 300W) until the contents of the vial reached a temperature of 40° C. In order to remove 
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excess copper and fluorophore, a buffer exchange was performed with Spin-X UF 
concentrator columns, and with PBS (8x200 μL) to a final volume of 50 μL. A control 
reaction was performed utilizing the same procedure, in absence of copper sulfate. The 
GFP was analyzed by SDS-PAGE (BioRad 10 % precast gels, 150 V, 1.5 h). Gels were 
imaged on a BioRad Molecular Imager (Gel Doc XR+), first via a Spyro Ruby irradiation 
to analyze fluorescence. Then, the gel was stained with Coomasie Brilliant Blue for an 
hour. The gel was then destained utilizing destain solution (60 % deionized water, 30 % 
methanol, 10 % acetic acid) until the gel was clear, after which the gel was analyzed via 
the Coomasie protocol on the BioRad Molecular Imager. 
Coolmate Glaser-Hay Procedure: GFP containing a UAA 32 at residue 151 (30 μl), 
AlexaFluor-488 alkyne (20 μl, 1 mM), CuI (5 μl, 500 mM), tetramethylethylenediamine 
(TMEDA; 5 μl, 500 mM), deionized water (1 mL), and a stir bar were added to a CoolMate 
vial. Perfluoro polyether was added to a CEM Discover Coolmate. Liquid nitrogen or dry 
ice was added to the cooling chambers, to cool the Coolmate to -50° C. The flow rate was 
turned on to a moderate to high level, and the contents of the vial cooled to -30° C, and 
were subjected to microwave irradiation (200 W or 300 W) until the contents of the vial 
reached a temperature of 40° C. In order to remove excess copper and fluorophore, a buffer 
exchange was performed with Spin-X UF concentrator columns, and with PBS (8x200 μL) 
to a final volume of 50 μL. A control reaction was performed utilizing the same procedure, 
in the absence of copper iodide. The GFP was analyzed by SDS-PAGE (BioRad 10 % 
precast gels, 150 V, 1.5 h). Gels were imaged on a BioRad Molecular Imager (Gel Doc 
XR+), first via a Spyro Ruby irradiation to analyze fluorescence. Then, the gel was stained 
with Coomasie Brilliant Blue for an hour. The gel was then destained utilizing destain 
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solution (60 % deionized water, 30 % methanol, 10 % acetic acid) until the gel was clear, 
after which the gel was analyzed via the Coomasie protocol on the BioRad Molecular 
Imager. 
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Chapter 6: Developing a Solid-Support Resin Method for 
Asymmetric Polyyne Synthesis 
 Polyynes are molecules containing an acetylenic scaffold, and are core structures 
found in various natural products.75-77 Over one thousand polyynes have been isolated from 
various organisms, and these compounds have been shown to exhibit therapeutic activity, 
such as antibacterial, anticancer, and antifungal properties.76-78 Due to the highly 
conjugated π-system, the acetylenic scaffold can also act as a molecular wire, with optical 
and conductive properties.79 The 
polyyne moiety was first 
developed by Glaser, who utilized 
oxidative dimerization of 
phenylacetylene via a copper (I) catalyst.80 Hay added catalytic amounts of copper (I) 
chloride with tetramethylenediamine (TMEDA) and oxygen.81 This allowed the reaction 
to be run at more neutral conditions, decreasing the temperature needed to run the reaction 
and allowing a greater variety of solvents to be used.81 The variant reaction, known as the 
Glaser-Hay reaction, forms symmetric polyyne molecules with relatively high yields 
(Scheme 6.1).81  
 One caveat associated with the Glaser-Hay reaction is it does not exhibit 
chemoselectivity when two different alkynes are reacted, and instead will form three 
different diyne products (Scheme 
6.2). The Young lab has 
previously employed polystyrene 
resin as a solid support to address 
Scheme 6.2 
Scheme 6.4 
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the chemoselectivity issues of the Glaser-Hay reaction, as well as eliminate much of the 
post-reaction workup.82 Solid-support synthesis allows easy removal of excess reagents, as 
well as structural rigidity (Scheme 6.3).82 Through this method, a library of asymmetric 
diynes can be synthesized. Also, different polyynes lengths can be achieved by coupling 
an immobilized alkyne with trimethylsilylacetylene (TMS acetylene), followed by 
cleavage of the protecting group. The synthesized diyne can undergo another round of 
polyyne extension, or capping with a different alkyne molecule. This allows the production 
of an asymmetric polyyne library. 
Scheme 6.3 
 
Results and Discussion: 
 My research focused on the synthesis of 8 polyynes (Figure 6.1), but many other 
polyynes were synthesized by other members of the lab. For each of the eight polyynes, 
propargyl alcohol was first immobilized. This was achieved by first swelling a 1% cross-
linked tritylchloride 
derivatized polystyrene resin 
in dichloromethane, followed 
by addition of propargyl 
Scheme 6.4 
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alcohol (Scheme 6.4). Based off previous results, it was found that alkyne loadings above 
0.7 mmol g-1 resulted in undesired dimerization of the immobilized alkynes.82 Thus to 
ensure asymmetrical polyyne synthesis, propargyl alcohol was immobilized at loadings of 
0.4-0.7 mmol g-1. For compounds, 33 and 37, the next step involved a Glaser-Hay reaction 
with ethynylanisole and hexyne capping groups, respectively. The reaction was optimized 
with CuI and TMEDA in THF for 16 hours at 60° C, and then washed with cycles of DCM-
MeOH (5 X 5 mL each). Alkyne extension followed a similar procedure, except that the 
Glaser-Hay reaction was done with TMS acetylene. The TMS group was then cleaved with 
TBAF in dichloromethane for 1 hour at room temperature. This step was repeated up to 
two more times, depending on the length of the polyyne, where afterwards, the capping 
alkyne was then installed. Utilizing ethynylanisole and hexyne capping groups, eight 
asymmetric polyynes were synthesized (Figure 6.1). 
 
 
Figure 6.1: Eight asymmetric polyynes synthesized using ethynylanisole and hexyne capping groups 
  
71  
 The yields of the asymmetric polyynes generally decreased with each alkyne 
extension, most likely due to the number of synthetic steps (up to 8 for the pentynes); 
however, yields were generally high (99-38 %). The hexyne capping group also resulted in 
lower yields than the ethynylanisole group. This could be a result of the increased 
conjugation of the anisole moiety creating a more 
reactive alkyne. In addition to an immobilized 
propargyl alcohol, an ethynyl benzene group was 
immobilized and capped with several alkynes. An ethynyl alcohol resin with a hexyne 
capping group was attempted (Figure 6.2); however, only the diyne was able to be 
synthesized. The hexyne capping group also showed lower than average yields for the 
immobilized propargyl alcohol.  
       Fluorescence measurements were obtained for various compounds, as these 
highly conjugated systems were hypothesized to exhibit unique fluorescent properties. For 
the ethynylanisole group, extended conjugation resulted in minor red and blue shifts, but 
the formation of the pentyne resulted in a large red shift (Figure 6.3). Other asymmetrical 
pentynes prepared by other lab members exhibited large blue shifts. This could be a result 
of the pentyne compounds transitioning into a polymeric state, exhibiting complex packing 
and interactions of the π-systems. The fluorescence measurements of the hexyne capping 
group differed greatly, as the triyne displayed a large red shift, while the other polyynes 
had smaller red and blue shifts (Figure 6.4). Despite the variability of the fluorescence, the 
results indicate that the optical properties of asymmetric polyynes can be tuned, depending 
on the capping group, and number of alkyne units. Fluorescence was also measured for a 
series of triynes with varying capping groups (Figure 6.5). Triynes with groups that 
Figure 6.2: A proposed asymmetric polyyne with an ethynyl benzene alcohol and a hexyne capping group. 
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extended the conjugation, such as phenyl and anisole produced blue shifts, with a small 
blue shift observed for the propargyl alcohol capping group. Current research is being done 
to further investigate and characterize the optical and conducting properties of the prepared 
compounds. Also, the technology can be extended to the preparation of the more complex 
and biologically active natural product derivatives. 
 
 
Figure 6.3: Emission spectra for the anisole polyynes after excitation at 330 nm.83 
 
 
Figure 6.4: Emission spectra for the anisole polyynes after excitation at 330 nm.83 
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Experimental: 
General: Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Tritylchloride resin, 100- 200 
mesh, 1% DVB crosslinking, was purchased from Advanced Chemtech. Reactions were 
conducted under ambient atmosphere with non-distilled solvents. NMR data was acquired 
on a Varian Gemini 400 MHz. GC/MS analysis was conducted on an Agilent Technologies 
6890N GC system interfaced with a 5973N mass selective detector. An Agilent J&W GC 
capillary column (30 m length, 0.32 mm diameter, 0.25 m film) was employed with a 
splitless injection (250° C inlet, 8.8 psi) with an initial 70° C hold (2 min) and ramped for 
15 min to 230° C. Fluorescence data was measured using a PerkinElmer LS 55 
Luminescence Spectrometer. 
Immobilization of Alcohol onto Trityl Chloride Resin in Low Loading Conditions: To 
flame dried vial was added trityl chloride resin (200 mg, 0.36 mmol, 1 equiv.) and 
Figure 6.5: Emission spectra of propargyl alcohol loaded triynes, with different capping groups.83 The capping groups are as follows: 7 – C2H2NH2, 11 – C6H5, 15 – CH2CH2CH2CH2, 19 - CH2OH, 23 – C5H4N, 27 – C6H4OCH3. Each molecule was excited at 330 nm.83 
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dichloromethane (5 mL). The resin was swelled at room temperature with gentle stirring 
for 15 min. Alcohol (25.0 µL, ~1.2 equiv.) was added to reaction, followed by 
triethylamine (10.0 µL, 0.072 mmol, 0.2 equiv). The mixture was stirred at room 
temperature for 16 h. The resin was transferred to a syringe filter and washed with DCM 
and MeOH (5 alternating rinses with 5 mL each). The resin was swelled in DCM and dried 
under vacuum for 45 min before further use. Resin loading was assessed via cleavage of 
15 mg resin in 2% TFA in DCM (200 L) at room temperature for 1 hour. After filtration 
of resin, loading was determined both by mass of cleaved product and by GC/MS analysis 
of integrated alcohol peaks from a standard curve and the cleaved resin. 
Polyyne Extension Protocol: Trimethylsilylacetylene (160 L, 1.05 mmol, 15 equiv.) was 
added to a flame dried vial containing the alcohol derivatized trityl resin (100 mg, 0.07 
mmol, 1 equiv.), and tetrahydrofuran (2.0 mL). The copper catalyst (20 mg, 1.06 mmol.) 
and tetramethylethylenediamine (20 µL, 0.132 mmol.) were added to a separate flame-
dried vial then dissolved in tetrahydrofuran (2.0 mL). The catalyst mixture was then added 
to the resin in one portion and stirred at 60° C for 16 h. The resin was transferred to a 
syringe filter and washed with DCM and MeOH (5 alternating rinses with 5 mL each). 
Regeneration of Terminal Alkyne: The TMS group was then cleaved by incubation in 
1M tetra-n-butylammonium fluoride trihydrate in DCM (TBAF, 1 mL, 1 h). Then the 
reaction was again transferred to a syringe filter and washed with DCM and MeOH (5 
alternating rinses with 5 mL each) and dried under vacuum for 45 minutes. Product was 
weighed and transferred to flame dried vial for future use. 
  
75  
Polyyne Capping: Soluble alkyne (15 equiv.) was added to a flame dried vial containing 
the desired alcohol derivatized trityl resin and tetrahydrofuran (2 mL). The copper catalyst 
(20 mg, 1.06 mmol.) and tetramethylethylenediamine (20 µL, 0.132 mmol.) were added to 
a separate flame-dried vial then dissolved in tetrahydrofuran (2 mL). The catalyst mixture 
was then added to the resin in one portion and stirred at 60° C for 16 h. The resin was 
transferred to a syringe filter and washed with DCM and MeOH (5 alternating rinses with 
5 mL each). The product was then cleaved from the resin by treatment with 2% TFA (DCM, 
1 h) and filtered into a vial. If necessary, a short silica plug was utilized to remove unreacted 
starting material (1:1 EtOAc/Hex). 
5-(4-methoxyphenyl)penta-2,4-diyn-1-ol, 33: The solvent was removed in vacuo to give 
33 as a solid (13 mg, 0.070 mmol, 99 %) 1H NMR (400 MHz; CDCl3): ∂ 7.44 (d, J = 7.6 
Hz, 2H), 6.85 (d, J = 7.6 Hz, 2H), 4.14 (s, 2H), 3.82 (s, 3H); GCMS (Rt=9.93 min) 
calculated for C12H10O2 186.1, found 186.2.  
7-(4-methoxyphenyl)hepta-2,4,6-triyn-1-ol, 34: The solvent was removed in vacuo to 
give 34 as a solid (10 mg, 0.049 mmol, 68 %) 1H NMR (400 MHz; CDCl3): ∂ 7.44 (d, J = 
7.6 Hz, 2H), 6.86 (d, J = 7.6 Hz, 2H), 4.38 (s, 2H), 3.82 (s, 3H); GCMS (Rt t=11.02 min) 
calculated for C14H10O2 210.2, found 210.3. 
 9-(4-methoxyphenyl)nona-2,4,6,8-tetrayn-1-ol, 35: The solvent was removed in vacuo 
to give 35 as a solid (11 mg, 0.037 mmol, 67 %) 1H NMR (400 MHz; CDCl3): ∂ 7.46 (d, 
J = 7.6 Hz, 2H), 6.84 (d, J = 7.6 Hz, 2H), 4.38 (s, 2H), 3.82 (s, 3H); GCMS (Rt = 18.39 
min) calculated for C16H10O2 234.3, found 234.2. 
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11-(4-methoxyphenyl)undeca-2,4,6,8,10-pentayn-1-ol, 36: The solvent was removed in 
vacuo to give 36 as a solid (8 mg, 0.031 mmol, 44 %) 1H NMR (400 MHz; CDCl3): ∂ 7.42 
(d, J = 7.6 Hz, 2H), 6.85 (d, J = 7.6 Hz, 2H), 4.42 (s, 2H), 3.82 (s, 3H); GCMS (Rt =14.35 
min) calculated for C18H10O2 258.3, found 258.2. 
deca-2,4-diyn-1-ol, 37: The solvent was removed in vacuo to give 37 as a solid (8 mg, 
0.058 mmol, 84 %) 1H NMR (400 MHz; CDCl3): ∂ 4.32 (s, 2H), 2.29 (t, J = 6.8 Hz, 3H), 
1.52 (m, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 0.91 (t, J = 7.23 Hz, 3H); GCMS (Rt =7.29 
min) calculated for C9H12O 136.1, found 136.0. 
dodeca-2,4,6-triyn-1-ol, 38: The solvent was removed in vacuo to give 38 as a solid (6 
mg, 0.037 mmol, 53 %) 1H NMR (400 MHz; CDCl3): ∂ 4.32 (s, 2H), 2.30 (t, J = 6.8 Hz, 
3H), 1.55 (m, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 0.93 (t, J = 7.23 Hz, 3H); GCMS (Rt = 
10.61 min) calculated for C11H12O 160.2, found 160.2. 4  
tetradeca-2,4,6,8-tetrayn-1-ol, 39: The solvent was removed in vacuo to give 39 as a solid 
(5 mg, 0.027 mmol, 38 %) 1H NMR (400 MHz; CDCl3): ∂ 4.36 (s, 2H), 2.30 (t, J = 6.8 
Hz, 3H), 1.55 (m, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 1.00 (t, J = 7.23 Hz, 3H); GCMS (Rt 
= 10.28 min) calculated for C13H12O 184.2, found 184.2. 
hexadeca-2,4,6,8,10-pentayn-1-ol, 40: The solvent was removed in vacuo to give 40 as a 
solid (9 mg, 0.028 mmol, 41 %) 1H NMR (400 MHz; CDCl3): ∂ 4.38 (s, 2H), 2.35 (t, J = 
6.8 Hz, 3H), 1.60 (m, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 1.02 (t, J = 7.23 Hz, 3H); GCMS 
(Rt = 11.71 min) calculated for C15H12O 208.3, found 208.3. 
Fluorescence Measurements: Each fluorescence spectrum was obtained in a glass cuvette 
with DCM (3 mL). To the cuvette solvent was added the asymmetric polyyne (500 μL, 10 
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mmol). The sample was excited at 330 nm and the emission spectral was recorded from 
350 nm to 600 nm; excitation slit width of 10 nm, an emission slit width of 10 nm, and at 
a scan speed of 400 nm/min. 
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Chapter 7: A Photosensitive Selenocysteine UAA 
 
There are certain amino acids that naturally exist outside of the canonical twenty 
that can also be utilized to make proteins. One such example is selenocysteine, which is a 
cysteine homolog with the sulfur atom replaced with a selenium atom. The other 
“unnatural” amino acid is pyrrolysine, which contains a pyrroline ring on the end of a lysine 
chain.84,85 Amino acids resembling selenocysteine and pyrrolysine are known as 
proteinogenic amino acids, and they serve important purposes for cellular function.84 
Selenocysteine, for example, has a low pKa and low reduction potential due to the selenium 
atom, which makes it useful for antioxidant activity.84 Pyrrolysine is used in methanogenic 
enzymes mainly found in archaea.5 These proteinogenic amino acids are incorporated into 
proteins co-translationally, and are encoded in mRNA in the form of stop codons. 
Pyrrolysine typically is encoded by the UAG (amber) stop codon, while selenocysteine 
uses the UGA (umber) stop codon.84,85 
Researchers have recently been interested in utilizing selenocysteine, especially 
due to its antioxidant activity.85 Several selenoproteins have been discovered in humans, 
including glutathione peroxidase and thioredoxin reductase.85 Naturally, selenocysteine is 
incorporated into proteins using the UGA stop codon, or a selenocysteine insertion 
sequence (SECIS), which is a unique untranslated portion of mRNA.85,86 Traditionally, the 
high reactivity of selenium atoms has made genetically encoding selenocysteine into a 
protein difficult. This process is essential if there is a need to specify the site of the 
selenocysteine residue. To counteract this, a caging protecting group can be added to 
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selenocysteine to make it less reactive, and able to be employed 
in aaRS selections. In one example, a 4,5-dimethoxy-2-
nitrobenzyl  (DMNB) caging group was attached to the selenium 
atom of selenocysteine, and incorporated with an enhanced green 
fluorescent protein (EGFP).87 By using an orthogonal 
aaRS/tRNA pair, the caged selenocysteine was successfully 
introduced into the protein.87 We propose an ortho-nitrobenzyl protecting group, to be 
incorporated into GFP (Figure 7.1). 
The incorporation of a caged selenocysteine into proteins offers a probe to 
understand the importance of this proteogenic amino acid in biological redox reactions. 
Also, a link has been established between selenocysteine-containing proteins and 
neurodegenerative disorders such as Alzheimer’s.88 A caged selenocysteine unnatural 
amino acid can elucidate the role of selenocysteine in neurodegenerative diseases, as well 
as further understand the underlying mechanism.  
Results and Discussion: 
 The synthesis of 41 proceeded in a multi-pot reaction (Scheme 7.1). The addition 
of the caging group necessitated the reaction to be prevented from light exposure, and was 
thus wrapped in aluminum foil upon reaction with the ortho-nitrobenzyl bromide reagent. 
Due to the charged amino acid backbone of the product, the reaction could not be extracted, 
but flash chromatography was attempted as a purification method. Compound 41 dissolved 
Figure 7.1: Proposed caged selenocysteine unnatural amino acid (41). 
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in a 10:1 DCM:methanol eluent mixture, and was transferred to the column. A gradient 
elution was then attempted, from 10:1 DCM:methanol to 1:1 DCM:Methanol, resulting in 
product recovery. Most likely, a high concentration of methanol is needed in the mobile 
phase in order to advance the product through the polar silica gel. This resulted in yields 
of over 100 %, which is most likely due to silica gel dissolution by methanol. The product 
was then analyzed via 1H NMR with D2O as a solvent, and 41 was observed in a 55.5 % 
yield. 
 With 41 synthetically prepared, incorporation of the UAA into GFP was then 
attempted. Since no aaRS has been evolved to explicitly incorporate 41, several aaRS 
assays were performed to examine aaRS promiscuity for 41. The pEVOL synthetases pAcF 
32/67, pCNF 32, ONBY, BipY, pCNF, and AzoF were investigated due to their large 
binding pockets, or structural similarities of their corresponding UAAs. Each aaRS plasmid 
was transformed with a pET-GFP-TAG-151 plasmid into E. coli. Cultures were grown, 
and GFP expression was induced in a 96-well plate with appropriate expression controls, 
as described in the general aaRS assessment protocol. Fluorescence of the cell cultures 
were measured on a microplate reader after 16 hours of expression (Figure 7.2). While 
most aaRSs were not able to accommodate the UAA, the results indicate that the pCNF-
aaRS was able to incorporate 41, when compared to a negative control grown in the absence 
of the UAA. The synthetase pCNF 32 was also able to incorporate an amino acid at a 
Scheme 7.1 
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relatively high rate. However, since the control incorporated an amino acid more than in 
the prescence of 41, it is more likely that tyrosine was being incorporated, and not 41.  
 
  
In order to elucidate if these results were truly valid, large scale GFP expression 
(30 mL) was attempted utilizing the pCNF synthetase. However, little protein was 
expressed and isolated. This could be due to the pCNF plasmid incorporating 5 poorly, but 
enough to indicate a higher result than the control. Therefore, a second synthetase screen 
was performed (Figure 7.3). The synthetases ONiF, 3FY, CuoA, and Nap were selected 
based on their large binding pockets, or similarities of their respective unnatural amino 
acid, and were analyzed in the same manner as described above. Unfortunately, no aaRS 
incorporated 41 better than a control, suggesting the need for an aaRS evolution 
experiment.  
 
0
200
400
600
800
1000
1200
1400
1600
AC 32/67 CN 32 ONBY BipY pCNF AzoF
RFU
aaRSs
Minus Plus
Figure 7.2: Synthetase assay for 41. Six synthetases were tested for their ability to incorporate 41into GFP at residue 151. The synthetase pCNF showed the most promise, as it incorporated an amino acid at a higher rate than the control. 
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Figure 7.3: A second synthetase assay for 41. Four synthetases were tested for their ability to incorporate 41 into GFP at residue 151. Unfortunately, no synthetase incorporated 41 in a greater amount than the control. 
 
 Several aaRSs have been employed, but none afforded a successful incorporation 
of 41. Other synthetases are currently being investigated; however, 41 may be difficult to 
incorporate due to the benzene ring being farther away from the amino acid backbone. This 
is problematic due to the tested aaRSs all incorporating respective UAAs that have been 
derived from tyrosine, which has a singular methylene unit separating the benzene from 
the backbone. Thus, an extended aromatic moiety may not properly fit into the binding 
sites. Therefore, an aaRS double sieve selection is being performed from a large library of 
aaRSs (~108), in order to find a synthetase the exclusively incorporates 41. Once a 
synthetase has been evolved or discovered that can incorporate 41, we are going to 
collaborate with Dr. Landino, in order to utilize the UAA to probe biological redox 
reactions. Specifically, 41 will probe oxidative damage as it relates to Parkinson’s and 
Alzheimer’s. 
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Experimental: 
General: Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Reactions were conducted 
under ambient atmosphere with non-distilled solvents. NMR data was acquired on a Varian 
Gemini 400 MHz. Fluorescence data was measured using a Synergy Microplate reader. All 
GFP proteins were purified according to manufacturer’s protocols using a Qiagen Ni-NTA 
Quik Spin Kit. 
General GFP Expression: A pET-GFP-TAG plasmid (0.5 μL) was co-transformed with 
a pEVOL-tRNA synthetase plasmid (0.5 μL) into Escherichia coli BL21(DE3) cells using 
an Eppendorf eporator electorporator. The cells were then plated (100 μL) on LB agar in 
the presence of chloramphenicol (34 mg/mL) and ampicillin (50 mg/mL) at 37° C 
overnight. One colony was then used to inoculate LB media (4 mL) containing both 
ampicillin and chloramphenicol. The culture was incubated at 37° C overnight and used to 
inoculate an expression culture (10 mL LB media, 50 mg/mL Amp, 34 mg/mL Chlr) at an 
OD600 0.1. The cultures were incubated at 37° C to an OD600 between 0.6 and 0.8, and 
protein expression was induced by addition of the respective unnatural amino acid (100 
μL, 100 mM) and 20 % arabinose (10 μL) and 0.8 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG; 10 μL). The cultures were incubated at 30° C for 16-20 h 
then pelleted at 5,000 rpm for 10 minutes and stored at -80° C for 3 hours. The cell pellet 
was re-suspended using 500 µL of Bugbuster (Novagen) containing lysozyme, and 
incubated at 37° C for 20 minutes. The solution was transferred to an Eppendorf tube and 
centrifuged at 15,000 rpm for 10 minutes, then the supernatant was added to an equilibrated 
column of Ni-NTA resin (200 µL) and the GFP was purified according to manufacturer’s 
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protocol. Purified GFP was analyzed by SDS-PAGE (BioRad 10 % precast gels, 150 V, 
1.5 h), and employed without further purification. Gels were imaged on a BioRad 
Molecular Imager (Gel Doc XR+), after being stained with Coomasie Brilliant Blue for an 
hour. The gel was then destained utilizing destain solution (60 % deionized water, 30 % 
methanol, 10 % acetic acid) until the gel was clear, after which the gel was analyzed via 
the Coomasie protocol on the BioRad Molecular Imager. 
General aaRS Assessment: The aaRSs were assessed for unnatural amino acid 
incorporation by first co-transforming a pET-GFP-TAG variant plasmid (0.5 μL) with a 
pEVOL-tRNA synthetase plasmid (0.5 μL), in a similar method as described previously. 
For each pEVOL plasmid, one colony was used to inoculate LB media (4 mL) in separate 
containers that contained ampicillin (4 μL, 50 mg/mL) and chloramphenicol (4 μL, 34 
mg/mL). The cultures were incubated at 37° C overnight. Expression cultures were created 
containing LB media (4 mL), ampicillin (4 μL, 50 mg/mL), and chloramphenicol (4 μL, 
34 mg/mL), and then were inoculated with the previous culture (250 μL). The expression 
cultures were incubated at 37° C to an OD600 between 0.6 and 0.8. Protein expression was 
induced by addition of 20 % arabinose (4 μL), and 0.8 mM IPTG (4 μL). The cultures were 
then plated on a 96-well plate (200 μL), with six wells for each plasmid. Three wells were 
designated as controls, and the other three were designated for the experiment. The 
designated UAA (100 μL, 100 mM) was added to the experimental wells only. The plate 
was allowed to shake at 30° C for 16 h, after which it was measured for fluorescence (528 
nm and 485 nm) utilizing a Synergy HT microplate reader. 
2-ammonio-3-((2-nitrobenzyl)selanyl)propanoate, 41: To a flamed dried vial was added 
seleno-L-cystine (22 mg, 5.98x10-5 mol, 1 equivalent), sodium hydroxide (320 μL, 0.5 M), 
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and ethanol (80 μL). The reaction was allowed to stir at 0° C. Once dissolved, sodium 
borohydride (16 mg, 4.23x10-4 mol, 7 equivalents) was added, and the reaction was warmed 
to room temperature, which was maintained for 5 minutes. The reaction was then cooled 
to 0° C, and sodium hydroxide (160 μL, 2M) was added, and allowed to stir for 5 minutes, 
while the reaction warmed to room temperature. Ortho-nitrobenzyl bromide (52 mg, 
2.39x10-4 mol, 4 equivalents) was then added, and the reaction was allowed to stir at room 
temperature for an additional 1.5 hours. Hydrochloric acid (500 μL, 1M) was added to 
neutralize the solution. The reaction was then concentrated via a rotary evaporator, and was 
purified via flash chromatography with gradient elution from 10:1 DCM/Methanol to 1:1 
DCM/Methanol, resulting in a yellow solid (20 mg, 6.60x10-5 mol, 55.5 %). 
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